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Abstract
Large quantities of contaminants enter Canadian waterways through municipal wastewater effluent (MWWE)
each year. MWWE exposure can have a myriad of effects on aquatic organisms, including inducing chronic
stress response or altering hormone signaling. A key site for many of these effects is the liver, which controls
xenobiotic metabolism, energy regulation, and other functions related to the maintenance of homeostasis.
One method for analyzing changes in liver function is shotgun proteomics, which uses mass spectrometry
data to identify and quantify proteins in a tissue or sample. The objective of this thesis is to investi-
gate changes in the liver proteome in fathead minnows caged upstream and downstream of wastewater
treatment plants (WWTPs) in the Bow River, Alberta.
To effectively analyze mass spectrometry data generated for this project, a fathead minnow specific pro-
tein database was constructed from the draft fathead minnow genome and corresponding annotations. The
constructed database is compared to the zebrafish reference proteome and UniProt Cyprinidae proteins
to determine differences between databases and the effect on protein identification rates. Additionally,
several different search engines, including de novo and database search engines, are compared against
different datasets to determine how mass spectrometry equipment and database accuracy affects protein
identification rates. Comparison of the databases showed that a species-specific database provided sub-
stantial increases in protein identification rates, with 461 (14.2%) more proteins identified than from the
zebrafish reference proteome and Uniprot database. Search tool comparisons revealed that while de novo
search engines can increase protein identifications within low quality databases, they are outperformed by
standard database search engines when an accurate and comprehensive database is available.
Shotgun proteomics was used to analyze changes in liver proteome of fathead minnows caged in five
sites along the Bow River around Calgary, Alberta, Canada. Sites were located upstream, downstream,
and close to the outflow of wastewater treatment plants (WWTPs) along the river. The constructed
database and a TMT-labelled fathead minnow mass spectrometry dataset are used to quantify protein
expression changes in the proteome. Differential expression analysis and gene set enrichment analysis are
used to compare expression profiles among different sites. 3689 proteins were identified in the fathead
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minnow proteome. Differential expression shows large changes in the liver proteomes of fish located near
the outflow of the Bonnybrook WWTPs, with a similar, but reduced effect at sites further. Proteins and
gene sets in involved in lipid metabolism, oxidative stress, xenobiotic removal were upregulated, while
mRNA splicing, and cytoskeleton organization were downregulated. Fish near the outflow also showed
changes in cell cycle control and protein modifications compared to fish further downstream.
Identifying changes in the liver proteome of MWWE-exposed organisms is important for identifying
potential biomarkers and understanding how exposure affect the health of aquatic organisms. Changes
in peroxisomal lipid metabolism and mitochondrial proteins suggest mitochondrial activity for further
study of the impacts of MWWE. Additionally, analysis of the impacts of species-specific database on
shotgun proteomics is useful for the application of omics to non-model organisms. Comparison of the
different database shows that even first draft genome sequences can produced substantially improved
protein identification rates over protein databases derived from other organisms.
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1.1 Municipal Wastewater Effluent
1.1.1 Contaminants in MWWE
Municipal Wastewater Effluent (MWWE) is a key source of contaminants in aquatic environments. More
that 86% of Canada’s population is served by wastewater treatment plants (WWTPs), which treat an
estimated 300–500L of waste water per capita daily.1–3 After varying degrees of treatment, that wastew-
ater is then discharged in nearby rivers, lakes, and oceans, and often migrates into groundwater as well.4
While wastewater treatment methods are generally effective at reducing carbon, nitrogen, and microbial
loads, concentration of other contaminants can be unchanged or even increased by different wastewater
treatment methods.5,6 The wide range of chemicals found in WWTP effluent is a result of the vast number
of pharmaceutical and personal care products (PPCPs), industrial chemicals, household wastes, and pesti-
cides that enter the wastewater system.4,7,8 A study of two WWTPs in the United Kingdom investigating
55 different PPCPs; including antibiotics, anti-inflammatory agents, antidepressants, and lipid regulating
agents, over a 5 month period found an average load of 6 to 10 kg/d in the influent, effluent, and receiving
waters of the plants.6
Besides PPCPs, a wide range of other contaminants are present in MWWE, including heavy metals,
persistent organic pollutants, pesticides, perfluoroalkyl acids, artificial sweeteners, industrial waste, and
chlorination and disinfectant byproducts.4,7,8 These contaminants, along with PPCPs, often remain in
detectable concentrations in MWWE, even after treatment, and are detectable in downstream surface
waters.2–4,7,9,10 Removal efficiencies vary drastically due to interacting effects of contaminant type and
treatment methods on the rate of degradation and sorption. Additionally, influent characteristics and
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treatment efficiencies change over time, both on a daily and seasonal scale.4,6,8 Observation of more
than 20 PPCPs in various wastewater treatment plant along the Bow River in Calgary, Alberta found
detectable concentrations in effluent and surface waters,11 and many of those contaminants were later
detected kilometers downstream of the nearest WWTP.12
Thus, MWWE is the primary source of hundreds of different anthropogenic chemical compounds found
in aquatic environments at various concentrations.1 Despite trends towards increased treatment, it remains
an important source of contamination of aquatic environments.2 Understanding the impact of MWWE on
aquatic environments will be an important factor in improving wastewater treatment methods.
1.1.2 Treatment of MWWE
Wastewater treatment is generally classified into three different categories, depending on the method of
processing and type of waste targeted for removal. The first and most common level of treatment, primary
treatment, uses sedimentation processes to remove the majority of suspended solids and reduce biological
oxygen demand.1,5 Primary treatment is generally found to be minimally effective at reducing PPCP
contaminant levels, as they remain in the aqueous phase rather than settling into the sediment, though
some highly adsorbed chemicals may be removed.5
Secondary treatment uses methods such as activated sludge or trickling filter beds to remove organic
material with aerobic or anaerobic microorganisms.1,6 Secondary treatment is where the bulk of easily-
degraded compounds, such as acetaminophen, are removed, either by biodegradation or abiotic chemical
processes.4,5 Compounds which do not biodegrade easily, such as carbamazepine, will pass through sec-
ondary treatment largely unchanged, or in some cases may even be regenerated by deconjugation of
metabolites present in the wastewater.4,6,13
Tertiary treatments are used for a variety of purposes, such as targeted removal of contaminants, or
disinfection of effluent by ultraviolet light, chlorination, or other methods. The impact of tertiary treatment
varies with different treatment methods and the type of contaminants present.1,2,13 While wastewater
treatment methods have improved over the last two decades, MWWE still has significant impact of the
health of downstream environments, especially with the variety of emerging contaminants like PPCPs
being introduced into municipal wastewater.2,14
1.1.3 Impacts of MWWE
The properties of PPCPs makes them inherently concerning as a contaminant. Pharmaceuticals are a
primary methods of patient care in modern medicine; commonly used pharmaceuticals are specifically
designed to be chemically stable and active in low doses, as they need to persist in the body long enough
2
to have effect in the face of physiological elimination mechanisms.6,13 For example, previous studies of an-
tidepressants such as venlafaxine have shown that over 30% of the treatment dose may be excreted directly
or as a biologically active metabolite.3 The lipid-lowering drug bezafibrate is excreted as more than 50%
active compound, and for pain management drugs, such as codeine or acetaminophen, more than 70% of
the dose may be excreted unchanged.6 The large volume of PPCPs can result in up to 3 kg/d of PPCPs
entering the receiving waters of a single plant serving 110,000 people, as is the case in the previously men-
tioned study in the UK.6 Generally these compounds will enter aquatic environments in large quantities.
Even if these contaminants are not toxic, or are found below toxic concentrations, exposure to PPCPs can
have chronic and sub-lethal effects, causing the dynamics of receiving water ecosystems to also be signifi-
cantly altered.1,2 Additionally, contaminants can have complicated interactive effects - multiple chemicals
may cause similar or overlapping disruptions in organisms, compounding effects beyond what would be
observed a similar level of an individual contaminant.2,3,9,15 For example, exposure to a combination of
carbamazepine and clofibric acid has been shown to be more dangerous than either alone13, and gemfi-
brozil, in addition to altering lipid metabolism, is an CYP450 inhibitor that may reduce metabolism of
other drugs, increasing the effects of exposure.16 Other factors, such as total dissolved oxygen and nutrient
levels, may also play a role in determining the toxicity and impact of particular contaminants.1,2 How-
ever, toxicity and thresholds of effect are usually determined for individual compounds13, and studies of
sub-lethal effects have generally focused on single compounds as well, limiting their use for understanding
the effects of complex mixtures.12
Studies of both general MWWE exposure and particular contaminants have identified a wide range of
impacts on aquatic organisms. Some contaminants, such as the pesticide dichlorvos, are of concern due to
their ability to ‘directly’ damage the exposed organism, inducing injury or death.17 Other contaminants,
pharmaceuticals in particular, are intended to alter biological pathways in humans. These pathways that
are often conserved in fish, leading to changes in behavior, metabolism, or other functions.18 Thus, while
exposure at environmentally relevant concentrations may not be toxic per se, PPCPs can impact a variety
of pathways that may reduce the fitness of a population.
For example, exposure to estrogenic compounds such as 17α-ethinylestradiol commonly found in MWWE
induces expression of the egg yolk protein vitellogenin and formation of oocytes in testis, and can alter
population sex ratios.14,18,19 A study using trout transferred from upstream controls sites to a MWWE-
exposed environment showed altered spawning patterns and increased vitellogenin in male fish.20 These
changes impact the ability of individuals to reproduce, reducing the overall population over time.
Exposure to PPCPs can also alter fish behavior and responses to environmental stressors. Experiments
with selective serotonin reuptake inhibitors has shown reduced territorial aggression, prey capture, and
feeding behavior in exposed fish.18 Caging studies in MWWE outflows has also shown changes in cortisol,
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the primary hormone involved in stress response and maintenance of homeostasis. Impacted fish are have
reduced ability to feed themselves, affecting growth and long term survival.
MWWE can also alter normal biological function within an organism. Many contaminant are known
to interact with the peroxisome proliferator-activated receptor (PPAR) transcription factors10,21, which
control fatty acid metabolism in many different tissues including heart, liver, muscle, and fatty tissue.22
These can result in changes in glycogen and lipid content in the organism, as well as alteration of enzymes
and pathway governing glucose and fatty acid metabolism.9,20
These types of changes in the exposed organism can impact fitness and reproductive success and can
reduce population levels of affected population. Thus, understanding the impacts of complex and variable
MWWE mixtures on aquatic environments requires analysis of a broad range of potential pathways that
may be impacted. Ideally, better understanding the impacts of MWWE would allow for identification of
various biomarkers that identify sub-lethal effect of exposure.
1.2 Liver Function in Teleosts
The diverse potential effects of MWWE allow for a variety of approaches for studying the effects of
exposure. One tissue with a large number of potentially impacted functions in fish is the liver. Many
contaminants are hydrophobic and accumulate in lipids and fatty tissues,10 and the liver accounts for
10-20% or more of total body lipids in fish.21 The liver also regulates a large number of key pathways for
xenobiotic metabolism, lipid metabolism, and hormone signaling in teleosts. Contaminants that disrupt
or alter liver function are common in MWWE,18 and can have significant impact on organism health and
fitness.9
1.2.1 Lipid Metabolism and Energy Regulation
The liver is a key site of lipid metabolism and gluconeogenesis. Unlike mammals, fish utilize lipids and
proteins as energy source better than carbohydrates.23 β-oxidation, or fatty acid oxidation (FAO) is a
process that occurs in both peroxisomes and mitochondria, during which fatty acids are transformed in
acyl-CoA and successively shortened by 2 carbons atoms, producing acetyl-CoA and a shorter acyl-CoA.24
The acetyl-CoA derived from this process enters the tricarboxylic acid cycle (TCA) in the mitochondria
for production of ATP and the regeneration of NADH and FADH2 through the oxidative phosphorylation
pathway. Alternatively, if excess acetyl-CoA is available, TCA intermediates will be exported from the
mitochondria for the generation of glucose through gluconeogenesis.10
In mitochondria, β-oxidation of long, medium, and short chain fatty acid (FA) is initiated by acyl-CoA
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dehydrogenase (ACAD), and the electrons produced are used in oxidative phosphorylation for energy gen-
eration.24 Mitochondrial FAO is primarily limited to dietary FAs, and transport across the mitochondrial
membrane is a rate limiting step.10 While short and medium chain FA can enter the mitochondria un-
modified, long chain FAs must be transported as acylcarnitine intermediates through the carnitine shuttle.
carnitine palmitoyltransferase 1 (CPT1) regulates mitochondrial β-oxidation by controlling the conversion
to acylcarnitine at the mitochondrial membrane.10
β-oxidation in the peroxisome is primarily limited to long and very-long chain FAs. While similar to
mitochondrial β-oxidation, electrons are not used in oxidative phosphorylation, and the initiating enzyme,
acyl-CoA oxidase 1 (ACOX1) instead produces H2O2 as a by-product during each round of oxidation.24
β-oxidation in peroxisomes does not proceed to complete shortening of the chain into acetyl-CoA as it
does in the mitochondria. Instead, carnitine O-octanyltransferase (CROT) converts shortened acyl-CoAs
to acylcarnitine intermediates for transfer to the mitochondria for complete β-oxidation. Peroxisomes
also contain modified and complimentary enzymes that allow for the oxidation of a wide range of other
compounds containing hydroxyl, methyl, and other large modifications, such as steroids or branched FAs
and FA derived signaling molecules like prostanoids.24,25 Thus FAO in peroxisomes plays a role in the
maintenance of signaling and regulatory FAs.
A variety of regulatory factors for FA metabolism exist. Acetyl-CoA in the cytosol, in addition to being
incorporated into the TCA or used in gluconeogenesis, may be carboxylated by fatty acide synthase into
the building block of fatty acid, malonyl-CoA. Malonyl-CoA also inhibits CPT1 activity, preventing entry
of long-chain FAs into the mitochondria for β-oxidation and favoring the synthesis and extension of FAs
for energy storage and export.
PPARs, occur in vertebrates as a family of three transcription factors that are key regulators of per-
oxisomal β-oxidation. PPARs function as nuclear receptors that dimerize with the retinoid X receptor
(RXR) and together bind the peroxisome proliferator response element (PPRE). PPARs are activated by
a variety of FAs, FA metabolites, and eicoseinoids, and regulate the expression of genes involved in FA
metabolism, glucose utilization, lipoprotein metabolism, lipogenesis, as well as inflammation and a variety
of other effects. In particular PPARα is highly expressed in liver and controls many FA metabolism genes.
Activation of PPARα increases the size and number of peroxisomes in liver tissue, as well as the rate of
β-oxidation.
1.2.2 Xenobiotic Transformation
Cytochrome P450s (CYPs) are a superfamily of heme-containing enzymes predominantly expressed in the
liver and catalyze oxidoreductase reactions, usually acting as a mono-oxygenase to incorporate hydroxyl
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groups into their substrate.26 CYPs play a role in metabolism of a large number of endogenous and
exogenous compounds and are important for the biotransformation of xenobiotics into water-soluble forms
for excretion.27
CYPs are broadly distributed in all eukaryotes, and 19 families of CYP genes have been identified in
vertebrates.28 CYP genes in families 5-51 are considered to be involved in the metabolism of endogenous
compounds, having higher substrate specificity and greater phylogenetically stability than families 1-4.
They have generally consistent distribution, frequency, and function across Vertebrata, most being part of
the metabolism of steroids, sterols, and signaling molecules.29 CYP51, for example, is found is all biological
kingdoms, where it is part of the sterol biosynthetic pathway.30
CYP families 1-4 play a prominent in role in xenobiotic response and metabolism.28 These families are
much more diverse than genes in families 5-51, and contain the majority of teleost-specific subfamilies.28,29
Substrate specificity is generally broader and the lack of similarity across organisms means the function of
these CYPs is less well understood compared to more conserved CYP families.31
The CYP1 family has been well studied as a biomarker, as it is known to respond to a wide variety
of contaminants including dioxins and polyaromatic hydrocarbons which activate the aryl hydrocarbon
receptor (AHR). A primary role of the CYP1 family is to oxidize carcinogenic compounds, increasing the
rate of excretion.26
CYP family 2 is the most diverse, with multiple lineage specific subfamilies and considerable functional
divergence across species.29 While the function of CYP2 isozymes are poorly understood, many play
a role in metabolism of both endogenous and exogenous substrates.29 CYP2K, for example, metabolizes
aflatoxin B1 in both zebrafish and rainbow trout, but metabolizes lauric acid only in rainbow trout.28 Many
CYP2 genes are located at conserved loci and have undergone diversification and expansion in different
organisms. The human CYP2J2 gene is located in a syntenic region with 11 CYP2 genes in zebrafish and
nine in mangrove killifish.29,31 Several of the CYP2 proteins found in this region oxidize arachidonic acid,
as does CYP2J2,29 and expression of the different CYP2 genes varies across tissue, developmental stage,
and xenobiotic exposure,31 suggesting diversification of CYP2 in response to specific metabolic needs.
CYP2 gene regulation in teleosts is largely unknown; the genes do not respond to AHR stimulation,
and known mammalian CYP2 inducers such as phenobarbitol do not induce CYP2 in teleosts.26,28,31 The
CYP2 family likely important in responding to a range of xenobiotics that varies with the environmental
conditions of the organism.
CYP families 3 and 4 are smaller and less diverse than family 2. CYP3 has 3 subfamilies, one of which is
only found in teleosts. CYP3A is found in both teleosts and mammals and is important for testosterone and
progesterone metabolism, and responds to various xenobiotics such a rifampicin and dexamethasone, while
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the functions of CYP3B and C subfamilies are not well understood.26,29 CYP4 genes are more common
in mammals than fish and are thought to be mostly FA hydroxylases that play a role in metabolism of
various signaling molecules. CYP4 expression is affected by exposure to fibrate drugs, and are potentially
under the control of the PPAR transcription factors, as they respond to xenobiotics known to alter PPAR
activity.26,29
1.2.3 Reactive Oxygen Species Metabolism
One byproduct of both FAO and the oxidative reactions performed by CYPs and other xenobiotic biotrans-
formation enzymes is an increase in reactive oxygen species (ROS). Peroxisomes and mitochondria are the
primary source of endogenous ROS.24 While a basal level of ROS is necessary for normal cell functioning,
particularly for cell-signaling through disulfide bond formation and breaking, excess ROS is damaging to
RNA, ribosome, lipid membranes, and cellular protein. Generally, cells attempt to convert the oxygen
radicals O·−2 to H2O2 with superoxide dismutase to prevent oxidative damage by ROS. Enzymes to convert
H2O2 to water, particularly catalase, peroxiredoxin, and glutathione peroxidase, then maintain H2O2 at
the necessary levels.32 However, increased production of ROS by β-oxidation or xenobiotic metabolism can
overwhelm the system. Glutathione peroxidase, for example, relies on a supply of monomeric glutathione
both for reducing H2O2 and biotransformation of lipophilic xenobiotics for excretion from the organism.
PPARα activation has been shown to increase H2O2 production from ACOX1 and CYP4, but also reduces
cellular levels of catalase, potentially leading to oxidative stress.24
1.2.4 Stress Response
A key pathway during stress response is the hypothalamus-pituitary-interrenal (HPI) axis, which mediates
the release of corticosteroids such as cortisol, the primary corticosteroid involved in stress response in
teleosts.33–35 After synthesis, cortisol is released from interrenal cells in the head kidney into the plasma,
where is circulates through the body. Cortisol is lipid soluble and thought to passively diffuse into cells,
though additional mechanisms of transport have been suggested.36 Once in the cytosol, cortisol binds to
the glucocorticoid receptor (GR) transcription factor. GR is then translocated to the nucleus where it
interacts with the DNA glucocorticoid-response elements to upregulate transcription.33,36,37
Cortisol is involved in regulating a variety of processes in hepatocytes as part of the stress response,
including gluconeogenesis and transcription of a wide range of genes.33,36. Studies suggest the primary
purpose of gene regulation through a GR within the liver is to control energy demand.36,38 In partic-
ular, cortisol upregulates expression of phosphenolpyruvate carboxykinase (PEPCK), a key enzyme in
gluconeogenesis,36,37 as well as suppressors of cytokine signaling (SOCS) genes, which suppress the Janus
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kinase-Signal Transducer and Activator of Transcription (JAKS-STAT).36 JAKS-STAT signaling mediates
energy demanding growth and immune pathways through expression of genes such as Insulin-like Growth
Factor and cytokine-mediated lipopolysaccharide-stimulated immune response.36,39 Additionally, cortisol
exposure has been shown to decrease GR levels through protein degradation while increasing transcription
rates of the GR gene.36
Non-genomic signaling has also been observed to occur in hepatocytes in response to cortisol signaling
in trout. Changing the fluidity and topology of plasma membrane of liver cells, induces phosphoryla-
tion of proteins kinases A and C and Akt, which are involved in signaling pathways regulating glucose
metabolism,34 as well as the transcription factor cAMP response element-binding protein.36 Similar changes
in membrane were not observed when cortisol synthesis was blocked.40
1.2.5 MWWE and Liver
Exposure to MWWE is known to have a variety of impacts liver-related functions in exposed fish. Exposure
studies have shown that fibrates and pharmaceuticals designed to alter FA metabolism in humans also
increases FA β-oxidation in fish.18,21 These pharmaceuticals alter PPAR activity in exposed organisms,
much like in humans, and exposure to MWWE can alter fatty acid and glycogen content and cause changes
in glucose and lipid metabolism.9 The increased xenobiotic metabolism and FA metabolism can increase
oxidative stress,21 and changes in oxidative stress response occurs with exposure to MWWE occurs in gill
and liver.20 Kling et al. [41] found that exposure to different concentrations of brominated fire retardants
could cause sex-specific changes in the liver proteome, with proteins involved in metabolism, such as α-
enolase and aldehyde dehydrogenase 8, being down regulated only in females and males, respectively. This
suggests that the proteome changes after exposure to MWWE may be gender specific.
Exposure to toxicants, such as those found in MWWE, are known to effect cortisol-mediated responses
in teleosts. Extended exposure to pollutants can induce chronic stress, resulting in an impaired response
to acute stressors.33,35,42 The stress response allows the organism to undergo physiological adaptations
to counteract threats to homeostasis; an impaired response counteracts the adaptive value and negatively
impacts organism fitness.43 In a field study of rainbow trout, an acute stressor showed significantly reduced
response in cortisol levels, as well as circulating glucose and PEPCK activity, in fish with a high degree of
MWWE exposure as compared to the unexposed control. Additionally, genes involved in cortisol synthesis
were suppressed 24 h post-stressor after exposure to MWWE as compared to the control, suggesting that
the HPI axis was not functioning effectively in response.35. Studies using caged trout near MWWE out-
lets has been shown to increase circulating cortisol as well as the amount of GR present in liver tissue.35
CYP11A1, an enzyme involved in the synthesis of cortisol from cholesterol showed altered expression at
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different levels of MWWE exposure.42 Endocrine disruptors, another common type of MWWE contami-
nant,2 have also been shown to interrupt function of the HPI axis.35 Exposure studies have found that to
atorvastatin impairs stress response, potentially due to altered cholesterol synthesis, along with lowering
levels of triglyceride levels and alterations in FA catabolism.21
The variety of metabolic function, and the multiple ways the MWWE can impact them, makes the
liver a key site for studying the impact of MWWE.
1.3 Proteomics
Determining the impact of MWWE on a organism can be difficult due to the broad range and interacting
effects of contaminants. Testing expression changes in a small number of genes, such as the GR or
P450scc, can be useful for understanding the impact on a particular function, but testing a large number
of individual genes or proteins is time consuming and expensive. Additionally, the variability of MWWE
composition and the interaction between components means the impacts of a contaminant mixture may
not be characterized well enough to know which genes to test.44
To combat these challenges, various ‘omics’ methods, including transcriptomics, proteomics, and
metabolomics, have become an increasingly common alternative to more targeted but less comprehensive
approaches.44 While the different ‘omics’ approaches have unique strengths and weaknesses, proteomics,
the large-scale identification and quantification of proteins45, has a few advantages that make it particu-
larly suitable for understanding the impacts of MWWE. While transcriptomics experiments usually yield
more comprehensive results, identifying a larger number of differentially regulated gene products46, protein
quantification data captures information on post-transcriptional and post-translational regulation that is
not available from the transcriptome, such as changes in synthesis and degradation of proteins.47 Proteins
are responsible for the majority of the cell’s function, and thus changes in the proteome more closely mimic
the changing phenotype of the organism.44,46 However, only a portion of the potentially 10,000 or more
proteins expressed in a typical eukaryotic organism can be detected in a single mass spectrometry run.47
1.3.1 Protein Identification by Mass Spectrometry
The key technology for proteome analysis is mass spectrometry (MS). Proteins or peptides are charged
by electrospray ionization (ESI) or matrix assisted laser desorption ionization (MALDI) and injected into
the mass spectrometer, where they are separated by mass-to-charge ratio (m/z) using a mass analyzer
such as a quadropole or Orbitrap, and the detected response as a function of m/z is quantified. By
scanning across a range of m/z ratios a spectra of ion intensities will be produced, which can be used to
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identify the injected ions. Since proteins are large and difficult to charge, the majority of experiments
use a ‘bottom-up’ approach in which enzymatically cleaved peptides are analyzed, whereas ‘top-down’
proteomics approaches, which use intact proteins, are rare.47 The most common enzymes used for cleavage
of proteins into peptides are trypsin and LysC, which cleave only at the the C-terminal side of lysine and
arginine residues.
While it is possible to identify proteins directly from the masses of their peptides – a process known as
peptide mass fingerprinting – the number of unique peptides with overlapping masses limits the effective-
ness of this technique for protein mixtures.45,48 To overcome this limitation, a variety of techniques have
been applied. Initially, proteomics experiments relied on separation of proteins by 2D gels followed by
identification of individual protein spots with MALDI-time-of-flight (TOF).44,45 Characterizing even a few
hundred of the most abundant proteins with this methods is time consuming, and advancements in mass
spectrometers and computing power has moved proteomics away from gel-based methods. The availability
of liquid chromatography mass spectrometry (LC-MS) systems, in which complex peptide mixtures are
separated by liquid chromatography and fed directly into the mass spectrometer by ESI, has allowed for
the analysis of complex mixtures without gel-based separation.46,47 This, along with the increasing speed
of mass spectrometers, has allowed the identification of thousands proteins in a single mass spectrometry
run, with the newest methods identifying up to 100 proteins/min.49
In addition to effective separation of peptides, proteomics also relies on tandem MS to identify the
sequence of individual peptides.48 Using two or more mass analyzers working in series, high abundance
precursor ions are isolated by m/z for collision with an inert gas, causing them to fragment into smaller
ions that are measured in the second mass analyzer.47 Ideally, precursor peptide ions would be fragmented
at each position in the peptide backbone, producing a spectra of ions separated by the mass of each residue,
though the process of fragmentation is complex and certain fragments are less likely.47 Fragmentation of
tryptic peptides tends to produce y type ions, one or more residues cleaved at the amide bond proceeding
from the C-terminus, though b type ions, which begin at the N-terminus, are also frequently observed.48
An example fragment spectra and the corresponding peptide identification can be seen in Figure 1.1.
The spectra produced from the ion fragmentation are then used to identify the precursor peptide. The
most common method is database searching,50 in which the observed fragment spectra and the precursor ion
m/z are compared to the theoretical fragmentation spectra of potential peptides from a protein database.47
Since even a small database of 10,000 proteins can contain more than 500,000 potential peptides, the
candidate peptides are limited to those with a calculated mass within a predefined range of the precusor
ion m/z. This reduces the number of peptide sequences to be scored against each spectra, and thus
the required computational time. Theoretical fragment spectra from these candidate peptides are then
compared to the observed fragment spectra and scored using a method particular to the search engine,
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Figure 1.1: Example spectra used to identify the peptide LALDIEIATYR with high confidence. The y and
b ions are indicated in orange and green, respectively. y ions predominate, but the majority of fragment
ions cleaved at the amide bond and larger than a single residue are observed. Most of the larger fragment
spectra (greater than 6 residues) are also found multiply charged, as indicated by the superscript of the
peak labels.
and the highest scoring sequence is assigned, producing a peptide-spectrum match (PSM).51
It is also possible to sequence peptides de novo based on the fragment ion pattern. Theoretically, if the
precursor is completely fragmented, the resulting ion spectra should contain peaks separated by the mass
of each consecutive amino acid residue. Since tryptic peptides end with a lysine or arginine residue, the
y1 ion mass should always have a mass of 147 or 175. By identifying the subsequent ions, the sequence
of the peptide can be identified from the difference between each peak. However, the combination of
missing fragment peaks, multiply charged fragments, fragmentation of the backbone outside the amide
bond, multiply fragmented ions, and contaminant ion spectra all make the clear identification of the full
peptide sequences computationally challenging and error prone.48 The most successful tools use de novo
sequencing in combination with database search to improve identification rates.50
1.3.2 Scoring Peptide Identifications
Theoretically, each spectra produced during a mass spectrometry experiment should correspond to a
peptide from the original sample; in practice, only 10-50% of PSMs represent true hits.52 This is due
to noise in the spectra, caused by factors such as incomplete fragmentation, or because the true peptide
sequence is absent from the database.51 Thus, after peptide-spectrum matching has been performed, some
method for distinguishing correct and incorrect PSMs is needed. While it is possible to simply decide a
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cut-off value for scores generated by the search engine, this provides no insight into the degree of confidence
in the PSMs, or the number of incorrect matches at a particular threshold.51
For database searches, most methods are based on the target-decoy approach first described by Elias
& Gygi [52], in which known ‘decoy’ peptide sequences, unlikely to exist in the sample, are added to
the database. These decoy sequences compete with the expected target peptides for the highest score
during the database search. Incorrect matches are assumed to be equally likely to occur with target and
decoy peptides, while correct matches are significantly more likely to occur with target peptides. Since
decoy peptides are assumed to be incorrectly matched, the false discovery rate (FDR) and a variety of
other statistics can be estimated from the number of decoy peptides at a particular score, allowing a
score cut-off to be selected at an estimated error rate.52 Extensions of the target-decoy approach include
PeptideProphet, which assigns confidences scores to PSMs based on which of two overlapping distributions
- correct and incorrect matches - the PSM is more likely to belong to, with the ability to use decoys to
better estimate the distributions.51
While the target-decoy approach provides an estimate of the FDR, it is limited to assessing PSMs as
independent observations within a single experiment. However, on both the peptide and protein level,
there are other factors to be considered in assigning confidence to peptide identifications. The simplest
case is multiple observations of the ‘same’ PSM - i.e. an ion with the same m/z ratio eluted at similar
times and matched to the same peptide - across multiple experiments. Intuitively, it would make sense
to assign a higher confidence to PSMs observed in 3 mass spectrometry runs than a PSM observed in
only one, even if the search engine assigned identical scores to both. Other similar scenarios include
multiply charged ions from the same peptide, or even multiple identifications by different search engines
employing different scoring algorithms. The iProphet software integrates results from multiple search
engines, multiple observations of the same precursor ion, multiple observations across experiments, and
multiply charged or post-translationally modified versions of the same peptide to increase or decrease the
confidence of individual PSMs.53 Finally, the ProteinProphet software calculates the confidence that a
particular protein exists in a sample, with increasing confidence for proteins with larger numbers of high
confidence peptides.54
1.3.3 Importance of the Protein Database
With the exception of de novo sequencing, the methods for identifying peptides and accurately assigning
confidence outlined in the previous sections are dependent on the correct peptide sequences existing in
the database being searched. All scoring functions rely at least partially on the similarity between the
observed ion spectra and the theoretical ones from a database, so the presence of the correct sequence, or
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a reasonably close approximation, is necessary for a high scoring match.50,51,55,56 While it is theoretically
possible to compare each spectra to all possible peptides, there are more than 1050 possible tryptic peptides
between 8 and 40 amino acids long, making the required computational time impractical. Additionally,
the target-decoy approach essentially relies on the ability to distinguish correct and incorrect hits based on
the distribution of scores; if the number of false positive hits is too high, the distribution of high-scoring
correct PSMs will be indistinguishable from randomly high-score false positives in both the target and
decoy databases.57,58
Thus, the protein database must meet a number of requirements: large enough to contain all potential
peptides in the sample, similar enough to the sample to be reliably matched to the experimental ion
spectra, but small enough to prevent inflation of false positives or excessive computational time. For
many of the organisms commonly studied by proteomics, particularly yeast, mice, and human samples,
comprehensive and well-curated proteomes are available, with the ability to include or exclude isoforms; for
aquatic organisms, zebrafish is similarly well studied. Unfortunately, the fathead minnow (FHM) genome
sequence was first released in 201659, and initial annotations were only released in 201760, limiting the
number of FHM specific proteins available in public databases. The challenges of database selection for
FHM will be discussed in depth in Chapter 2.
1.3.4 Protein Quantification and Isobaric Mass Tagging
There are multiple methods for performing quantification of proteins during LC-MS. Label-free quan-
tification, perhaps the most conceptually straightforward method, compares the intensity of precursor or
fragment ion peaks across multiple MS runs. While conceptually simple, label-free quantification requires
complex matching of the spectra from different samples, and requires an individual MS run for each sam-
ple in the comparison.46,47 stable isotope labeling with amino acids in cell culture (SILAC) and other
metabolic labeling techniques involve growing one of a pair of samples in the presence of an amino acid
labeled with a heavy carbon or nitrogen isotope (i.e. 13C or 15N). When the combined heavy and normal
samples are run on a high resolution mass spectrometer, the spectra from each sample differ by the mass
of the isotopes, allowing the relative abundance to be determined from the relative height of the peaks.
However, SILAC and other metabolic labeling methods require the ability to grow cells in highly controlled
conditions, to ensure proper labeling of proteins by the isotope.47 Additionally, only two samples can be
compared at once.
Isobaric mass tagging provides a method for multiplexed comparisons in a single MS run. Following
a tryptic digest, a chemical tag with an amine reactive group is added to the sample, where it bonds
to the amine (N-) terminal of the peptides. Different samples receive tags that are structurally identical
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Figure 1.2: Example reporter ion spectra for TMT-10plex tags. Peaks corresponding to the 6 major
reporter ion m/z of 126,127,128,129,130,131 can be seen, but the difference between the 13C and 15N
report variants cannot be seen at this scale.
and equally massive (isobaric), but contain a unique arrangement of carbon, nitrogen, and oxygen iso-
topes across the structure. The peptides from different samples are then pooled together and run through
LC-MS system. Since the tags are isobaric, similar peptides across samples are eluted and ionized at the
same time. During fragmentation, however, the tags split into three pieces - a unique reporter group, with
a characteristic m/z between 100–150Da, a small balance group, and the amine reactive group, which
remains bonded to the peptide. Reporter groups from each tag contain slightly different distributions
of isotopes, causing small mass differences between them. This creates a distribution of reporter ions in
which the m/z of the ion identifies the original sample, and the intensity of that ion is proportional to the
relative abundance of the peptide (Figure 1.2). The balance group contains a complementary isotope dis-
tribution, so that the combined mass of the reporter group and balance group is the same for all tags. This
mean the amine-bonded reactive group has an identical mass in all samples, so the fragmentation pattern
produced for the peptides from the different samples is identical, which simplifies peptide identification.
Since the peptide ion intensity is cumulative across the multiplexed samples, identification rates for low
abundance peptides are increased, and the selected precursor ions are more consistent between different
samples compared to label-free methods.61 With TMT-10plex tags allowing up to 10 different samples to
be combined in a single run, the number of experimental conditions and replicates can be significantly
increased without requiring additional instrument time.
However, the need to accurately distinguish and quantify reporter ions when using isobaric mass tags
introduces some drawbacks and experimental complications. The small mass differences between the
reporter ions, particularly the 6.32mDa difference between some TMT-10plex tags, requires the use of
high resolution mass analyzers to properly resolve low m/z reporter ion peaks for quantification.62 The
most significant flaw in isobaric mass tagging is that quantification from the reporter ion spectra assumes
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that all reporter ions are sourced from the same peptide, but experimental results have shown that the
complex samples derived from tryptic digest of full proteomes can result in multiple precursor peptide ions
to be selected simultaneously.63 The reporter ion overlap between multiple peptides reduces the relative
differences between reporter ions, underestimating the fold-change between different samples, an effect
known as ratio compression.61
Multiple methods to combat ratio compression have been proposed, ranging from sample preparation
to statistical analysis.63,64 A common approach is to reduce complexity by prefractionating samples and
running them separately, which reduces the number of peptides being eluted in a given time window.
However, prefractionation cannot fully prevent co-eluting peptides and introduces other fraction-specific
effects, as well as drastically increased instrument time to run multiple samples.61 More recently, MS3-
based methods have been introduced. Originally, reporter ions were fragmented and quantified during
MS2, along with the peptide fragment ions. With newer instruments, by careful selection of instrument
settings, only the peptide backbone can be fragmented during MS2, while the reporter tags remains intact
on the new fragment ion.65 Multiple fragment ions in the MS2 spectra are then simultaneously selected
and fragmented again with higher energy, breaking the tags and producing reporter ion spectra from a
limited set of peptides.66 By limiting the signal from co-eluting peptides and other contaminants, the ratio
between reporter ions is more accurately reported, significantly reducing compression.65
While MS3-based quantification significantly improves the accuracy of quantification, it incurs several
trade-offs. The requirement of an additional MS scan for each isolated precursor ion reduces the total
number of scans that can be performed in a given run, and requires the use of specialized triple mass
spectrometers. The method also requires that MS2 spectra be analyzed in the less accurate linear ion
trap, reducing the accuracy of the peptide fragment spectra. The combined effect is a decrease in total
number of peptides, and thus proteins, identified from the sample.65,66
1.4 Conclusion
Investigation of the liver proteome is an important tool to better understand the impacts of MWWE expo-
sure. The liver is a primary target for the hormones produce by the HPI axis, including cortisol, and helps
regulate metabolism through glucose and lipid metabolism. Exposure to MWWE effects liver function,
changing expression for a variety of genes involved in metabolism, homeostasis, and stress adaptations.




Construction and Testing of a
Fathead Minnow Protein Database
2.1 Introduction
Analyzing changes in protein expression is a key part of understanding in a biological organism. While ad-
vances in RNA sequencing technologies have made transcript level measurements increasingly accessible67,
mRNA levels are generally poorly correlated with protein abundance. A variety of cellular mechanisms,
such as targeted protein degradation and post-transcriptional regulation, impact the correlation between
mRNA and protein abundance.68 Under some conditions protein abundance can be negatively correlated
with mRNA levels, such as the glucocorticoid receptor (GR) in teleosts, reflecting additional controls on
protein expression in addition to mRNA abundance.36 Thus, investigating changes in the proteome allows
researchers to capture the state of the molecular ‘machinery’ carrying out cellular function, rather than
the ‘blueprints’ for those machines, providing an additional layer of insight into the biological function of
the cell.
Currently the dominant method for proteomics analysis, shotgun proteomics, produces large scale
identifications of proteins in the proteome by utilizing nanoLC and tandem mass spectrometry (MS)
technologies.46 A key step in the data analysis of proteomics experiments is identifying the original peptides
from the mass spectra produced. Depending on research goals, it may also be important to identify proteins
variants and modifications, which also affect the mass spectra produced.
A key factor in shotgun proteomics is the database used for protein identification. Generally, proteomics
experiments rely on the availability of comprehensive protein databases for reliable peptide identifications,
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limiting the application of proteomics when a database is not available.69 While well-studied model organ-
isms, such as zebrafish (Danio rerio), have comprehensive protein sequence information readily available for
proteomics work, such is not the case for non-model organisms.70 While the fathead minnow (Pimephales
promelas) is commonly used for aquatic toxicology studies,71 there is little protein sequence data available
in public repositories such as the Uniprot.72
As mass spectrometry and sequencing technologies have become increasingly ubiquitous the field of
proteogenomics, the integration of nucleotide sequence data and proteomics analysis, has arisen.73 The
combination of RNA sequencing data and proteomics had led to multiple tools for generate sample spe-
cific protein databases from both de novo and reference-based transcript assemblies.67,69,74 Proteome data
has also been combined with genome sequence data to produce protein databases for prokaryotic organ-
isms,75–77 or to identifying point mutations.78 However, to the author’s knowledge, while genome-based
protein identification has been discussed since the early days of proteomics,48,77, little has been done to
specifically analyze the impact of genome-derived predicted proteins as a database source compared to
publicly available protein databases. Predicted gene sequences from a sequenced genome have primarily
been used for updating and re-annotating existing protein annotations or to add protein sequences to an
existing species specific database,79–81 with few attempts to use purely genome-derived sequences for a
protein database.70,82,83
Many search engines exist to map MS spectra to corresponding peptides. Two popular tools are
X!Tandem and Comet, which score observed mass spectra against predicted spectra computed from a
database of proteins.47 More recent tools attempt to improve on these methods to increase peptide iden-
tification rate. These include MSFragger, which performs fast searching of spectra with large mass varia-
tions56, and de novo peptide sequencing tool PEAKS, which combines customized database search engines
with de novo peptide sequencing methods.50 To produce accurate and reproducible results, it is important
to determine how these different tools perform, in terms of both the number of protein identifications, and
the degree of similarity in the identifications, and the ability to identify modifications to proteins.
In this chapter, we describe the creation of a proteomics database using the publicly available gene
annotations of the fathead minnow genome,59,60 and analyse the effect on protein identification as compared
to the general purpose UniProt database and the zebrafish reference proteome.72 By using existing protein
annotations, identified proteins can be directly associated with with annotation in the fathead minnow
(FHM) genome. We also compare the performance of several popular search engines, including open-source
tools X!Tandem, Comet, MSFragger, and the commercial program PEAKS on multiple mass spectrometry
samples. Search engine comparisons were made using three datasets: the FHM-specific database and FHM
MS data described in this thesis, as well as two other datasets previously generated in the McConkey Lab;
one trout dataset generated using different MS equipment and a human dataset generated with the same
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MS equipment as the FHM data.
2.2 Methods
2.2.1 Database Comparison
Three databases will be used for the purposes of database comparison. The first is the Fathead Minnow
Predicted Proteome (FHMP), which is constructed from annotations of predicted protein-coding regions
in the FHM genome sequence produced by Saari et al. [60]. Two sets of annotations from that work
were used for database construction. One set of annotations is from the de novo gene predictions software
Augustus, and the other from the alignment of zebrafish transcripts to the FHM genome using the program
exonerate.60 Construction of the FHMP is described below.
The UniRef90 Cyprinidae Proteome (U90CYP)84 and the Uniprot Zebrafish Reference Proteome (ZRP)72
are used for comparison. U90CYP is composed of the reference sequences for all proteins in UniProt with
”Cyprinidae” in the taxonomy, clustered at 90% identity. The ZRP is the UniProt reference proteome for
zebrafish.
Proteome Construction
The FHM genome sequence,59 along with ab initio Augustus gene prediction and zebrafish transcript
alignment annotations,60 were downloaded from the Society for Environmental Toxicology and Chemistry
(SETAC) website on October 24th, 2017.85 An in-house python script (Appendix A.1) using the gffutils
python package86 was used to collect all the protein coding regions from the genome sequence data.
For each of the Augustus-predicted genes, coding sequence regions were concatenated into a single open
reading frame (ORF). ORFs were checked for completeness, requiring an in-frame coding sequence with
start and stop codons at each end, and any incomplete ORFs were dropped. The coding sequences were
then translated into the corresponding protein sequences.
For the aligned zebrafish transcripts, the exons were concatenated, then translated into protein se-
quences using TransDecoder87. TransDecoder identified ORFs longer than 80 residues and scores them for
likelihood of translation. Additionally, it searched the ORFs against a database of all UniprotKB teleost
sequences using Blastp88 and against the Pfam89 domain database using hmmscan90. High scoring ORFs,
along with those containing blast or Pfam domain hits, were translated to protein sequences.
The two interim protein sequence databases derived from the Augustus gene predictions and zebrafish
transcript alignments were assessed for completeness using the Benchmarking Universal Single Copy Or-
thologs (BUSCO) software suite91 with the Actinopterygii lineage dataset. BUSCO assess the completeness
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Figure 2.1: Construction of the FHMP from FHM genome annotations.
of genomes, transcriptomes, and proteomes by identifying and quantifying genes normally found as sin-
gle copies in other members of the same taxonomic group. This serves as an estimate of what fraction of
genes in the original organism are found in the dataset. Results were visualized using the provided BUSCO
plotting tool. Additionally, DOmain-based General Measure for transcriptome and proteome quality As-
sessment (DOGMA)92 was performed using conserved domain arrangements (CDAs) up to length three
from the vertebrate CDA collection to analyze the functional portions of protein sequences. Analysis of
CDA by DOGMA is an alternative quality measure to BUSCO. DOGMA identifies the frequency and
order of sets of conserved Pfam domains to measure the completeness of a proteome.92 Since domains usu-
ally have conserved and independent function, measuring domain frequency indicates functional, rather
than sequence-level, completeness. The protein sequences from the annotations were then combined into
a single, concatenated Fathead Minnow Predicted Proteome (FHMP) database.
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Proteome Quality Testing
After proteome construction, additional reference databases were compared with the generated Fathead
Minnow Predicted Proteome. The UniRef90 Cyprinidae Proteome (U90CYP)84 and the Uniprot Zebrafish
Reference Proteome (ZRP)72 were downloaded for comparison to the FHMP. The proteomes, as well as
the FHM genome, were analyzed for completeness using BUSCO with the Actinopterygii lineage dataset,
as well as DOGMA using the vertebrate dataset. Since DOGMA does not work on complete genomes,
DOGMA analysis was not performed on the FHM genome.
Effects of DB Size and Redundancy
Confident identification of proteins from mass spectrometry data requires peptides that map uniquely to
that protein and no others. Redundant proteins were removed from the FHMP using cd-hit93 to reduce
repetitive protein sequences in the proteome. Proteins were clustered at a range of identity thresholds
of 85%, 90%, 95%, and 100%, and the longest protein in each cluster was kept in the proteome as the
reference sequence. BUSCO and DOGMA analyses were performed after clustering the FHMP at each
threshold value to identify the effects of clustering on the proteome completeness.
In order to assess the frequency of unique peptides, an in-silico tryptic digest was performed with a
custom python script (Appendices A.3, A.4) for the initial FHMP and at each identity threshold, as well as
the ZRP and U90CYP. Tryptic peptides between 2 and 35 residues were retained, with up to one missed
cleavage, for all protein sequences in the database. The number and length of all possible peptides (unique
peptide sequences) in the proteome were calculated, as well as the number of occurrences of each peptide
sequence. The uniqueness of the proteome was calculated as the fraction of single occurrence peptides over
the total number of possible peptides in the proteome for peptide lengths 2 through 35. Additionally, a
six-frame translation of the fathead minnow genome was performed in-silico using EMBOSS transeq94 to
create a database of all potential peptides, except those spanning exon juctions, and the set of peptides
was compared to the set of peptide of the U90CYP and the FHMP.
To investigate the effects of proteome size and redundancy on a decoyed database, the complete UniProt
Actinopterygii protein database was also downloaded and randomly sub-sampled at various sizes. Decoys
versions of the databases were created by pseudo-random shuffling using the Trans-Proteomic Pipeline
(TPP)95 decoy generation tool to add decoy proteins, and an in-silico tryptic digest was performed.
Pseudo-random shuffling generates decoys by ‘cutting’ each protein sequence into peptides after particular
residues, shuffling the sequence between those residues, then joining the peptides back together in the
same order. This creates randomized decoy proteins with similar amino acid compositions and length
distributions as the target set. For decoy generation, the default residues were used for shuffling: glycine
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and phenylalanine, except when they preceded asparagine. The database and subsamples were then
clustered at 95% identity, and the decoy generation and tryptic digest were repeated. The overlap between
decoy and target peptides, as well as the total number of peptides, was calculated based on peptide
sequence for both the original, redundant databases and the versions clustered at 95% identity.
Following analysis of the proteome for completeness, duplication, and the effects of clustering, the final
FHMP was clustered at 90% identity for subsequent analysis.
Effect of database on search results for a FHM dataset
In addition to the comparison of search engine performance on different datasets described in Section 2.2.2,
the effect of different protein databases on protein and peptide identification rates was compared using
the FHM MS dataset. Details on the MS data generation can be found in Section 3.2.2. A proteomics
pipeline were run for the three different protein databases:
• FHMP at 90% identity: 37,454 sequences
• U90CYP: 42,248 sequences
• ZRP: 25,747 sequences
The 6-frame translation of the FHM genome was excluded from the comparison because 6-frame trans-
lations are known to perform poorly compared to other databases due to the over-abundance of ‘incorrect’
target sequences in the resulting database.58 Decoys were added to each dataset by pseudo-randomly shuf-
fling the sequences. The Comet and X!Tandem search engines were used for the peptides search against
each database. Results from the different runs and search engines were scored and combined using the
PeptideProphet, iProphet, and ProteinProphet data analysis tools in the TPP. Results were compared on
the basis on overall number of proteins identified, the number of peptides, and the peptides matched to
each spectra in the MS dataset.
2.2.2 Search Engine Comparison
In order to compare the effectiveness of different search engines and data analysis tools, proteomics pipelines
were run on three liquid chromatography mass spectrometry (LC-MS) datasets generated in the McConkey
lab (Table 2.1). The FHM MS data is the same as used for the FHMP database testing (Section 2.2.1),
described in Section 3.2.2. The Human dataset was generated using the same MS equipment and conditions
as the FHM MS data, while the Trout dataset was generated using the higher-accuracy Orbitrap rather
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Table 2.1: Details for each sample used in the peptide search comparison
Human Trout Fathead Minnow
Tissue Breast cancer cell culture Liver Liver
Digestion Trypsin/LysC Trypsin Trypsin/LysC
Mass Spec Fusion Lumos Q-Exactive Fusion Lumos
MS Runs 1 3 3
MS2 Spectra 146,082 122,227 144,532
MS2 Source Ion trap Orbitrap Ion trap
Database Uniprot Human Proteome Uniref100 Rainbow Trout FHM Gene Predictions
Database size 93,591 49,519 23,191
than the ion trap used for the Human and FHM datasets.66 This allows for consideration of database
accuracy and the effects of different MS conditions when comparing search engine results.
The databases used were a FHM protein database generated from the genome using only the de-novo
gene predictions clustered at 90% identity. The Uniprot human reference proteome72 and the Uniref
proteins found in Oncorhynchus mykiss clustered at 100%84 were used as the human and rainbow trout
databases, respectively. For consistency in search results, decoys were generated and concatenated to
the FASTA database once for each database using PEAKS Studio50 v8.5 and used for all search engines.
The decoyed databases were searched using Comet55, X!Tandem96, MSFragger56, and PEAKS50. Search
parameters were kept as similar as possible for all search engines, allowing for up to one missed cleavage,
with TMT10plex tags and carbamidomethylation as fixed modifications and oxidation of methionine as a
variable modifications. For MSFragger, which is designed to search a large mass range, the precursor mass
tolerance range was set to ±500Da. The precursor tolerance for PEAKS, Comet, and X!Tandem was set
to 10 ppm for the Human database search, and 15 ppm for the FHM database search, typical ranges for
ion-trap MS spectra, while the higher accuracy Orbitrap spectra in the Trout dataset were searched at
0.1Da. Additional parameters are included in Appendix A.2.
The rate of false positives was estimated from hits to decoy proteins in the database. An estimated
1% false discovery rate (FDR) was used as the cutoff for protein identification from each search en-
gine. For X!Tandem, Comet, and MSFragger, post processing with PeptideProphet51, iProphet53, and
ProteinProphet95 was used for integration of peptide and protein identifications across runs, as well as
post-translational modification (PTM) identification. For PEAKS, PTMs and modifications were identi-
fied with the PTM and SPIDER search engines. Scan numbers were used to identify which spectra were
mapped to peptides by each search engine, and the identified peptides and proteins were matched by
sequence and protein ID, respectively, to determine similarity between search engine results.
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2.3 Results and Discussion
2.3.1 Generation of Protein Databases from Genomic Sequence
Constructing the FHMP database from the genome sequence and annotations yielded a total of 65,236
protein sequences, 42.5% (27,784) of which were derived from Augustus-predicted gene annotations, and
57.5%(37,454) from the locations of aligned Danio rerio transcript annotations.
The Benchmarking Universal Single Copy Orthologs (BUSCO) dataset was used to compare the com-
pleteness of the proteins from each annotation set, as well as the combined FHMP. This assesses if
protein sequences could be successfully be constructed from the genome sequence and annotations, and
the redundancy of the protein sequences from the two different annotations.
Construction of the FHMP produced complete copies of 3468 of the single-copy orthologs, or 75.7%
of the 4,584 genes in the Actinopterygii gene set. 569 BUSCO genes are missing, and another 547 are
duplicated, while over 2000 of the complete BUSCO genes are found in duplicate (Figure 2.2aiii). The
duplication is due to redundancy within the aligned transcripts and between the aligned transcripts and the
Augustus-predicted genes. All but 385 proteins found in the final protein database are present in the aligned
transcripts (Figure 2.2aii), and 1162 are present in more than one copy. Despite the redundancy, combining
the two datasets still increased the total number of complete Actinopterygii single-copy orthologs.
Figure 2.3a compares the results of BUSCO analysis on the initial FHMP prior to removing redundant
sequences, the full FHM genome, the UniRef90 Cyprinidae Proteome (U90CYP), and the Uniprot Zebrafish
Reference Proteome (ZRP) against the 4,584 single-copy orthologs found in the OrthoDB v9 Actinopterygii
database. The U90CYP is nearly complete, with 98.0% of genes found, but also contains 25.6% of complete
genes in more than one copy. Given that Uniprot collects protein sequence from a wide variety of organisms,
including both predicted and experimentally observed proteins, the high degree of completeness and a
degree of duplication is not surprising.
While BUSCO analysis of the manually curated zebrafish genome identified complete copies of 96.7%
of the expected genes with a low rate of duplication, 23.5% of all BUSCO genes lack complete copies in
the FHM genome sequence. This is consistent with the 74% of conserved eukaryotic genes found by the
authors of the original genome sequencing. The missing genes are likely due to the fragmented nature of
the genome, as only short-read sequencing technologies were used for genome assembly.59 However, the
FHM genome also shows a reduced rate of gene duplication compared to the ZRP, again likely due to the
incomplete nature of the FHM genome.
The number of detected complete BUSCO genes decreased by 38 from the FHM genome to the FHMP



























Figure 2.2: Assessment of FHMP completeness by BUSCO and DOGMA. a) Detected BUSCO genes in
proteins converted from: i) de novo gene predictions ii) aligned zebrafish transcripts iii) the two sources
combined with no redundancy correction. b) CDAs detected in proteins converted from de novo genes





























Figure 2.3: Comparison of protein database completeness by BUSCO and DOGMA. a) Detected BUSCO
genes in i) the UniRef90 Cyprinidae Proteome (42,248 protein sequences) (ii) the Uniprot Zebrafish Ref-
erence Proteome (25,747 protein sequences), iii) the Fathead Minnow Predicted Proteome (65,236 protein
sequences), and iv) the Fathead Minnow (FHM) genome. b) Detected vertebrate CDA in the UniRef90
Cyprinidae Proteome ii) the Uniprot Zebrafish Reference Proteome, iii) the Fathead Minnow Predicted
Proteome. Length indicates the number of domains in the CDA.
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or early termination of proteins, resulting in the loss of one end of the sequence. Additionally, BUSCO
uses Augustus with specific training parameters to predict the location of genes in the gene set, which has
been shown to perform better than using pre-trained parameters from another species91 as was done for
the FHM genome annotations.60 Both of these factor would result in more gene being detected by BUSCO
than were present in the annotations to translate.
In addition to sequence-level BUSCO analysis, identification of conserved domain arrangements (CDAs)
was performed using DOGMA. Since DOGMA identifies sets of protein domains, rather than whole genes,
it estimates the degree to which functional portions of proteins are present. Despite the difference in
method, the results of CDA and BUSCO analysis are largely consistent for the protein sets (Figure 2.3),
with CDA completeness being slightly higher than the identification rates in BUSCO. For the FHMP, the
overall average is consistent with BUSCO scores, however completeness decreases strongly with increasing
CDA length. This further supports that the FHM genome, and the resulting protein database, is highly
fragmented and producing incomplete protein sequences.
Reducing Database Redundancy Improves Peptide Search Space
The purpose of BUSCO is to benchmark genome assemblies and gene sets using near universally-present
single-copy orthologs. Results indicate that 59.7% of all detected complete genes in the FHMP (Figure
2.3ad) are duplicates showing that the FHMP is heavily redundant.
In-silico tryptic digest of the U90CYP, ZRP, and FHMP also support that the FHMP and U90CYP
databases are redundant (Figure 2.4a). The ZRP is well curated and contains a limited set of proteins
meant to completely represent the Zebrafish proteome. While the Zebrafish reference is less than 50% of the
size of the FHMP at 25,747 protein sequences, it contains more possible tryptic peptide than the FHMP,
and over 90% of tryptic peptide sequences longer than seven residues occur only once in the database.
The U90CYP and FHMP contain less than 70% and 50% unique peptides longer than seven residues,
respectively. Thus, while the U90CYP and FHMP contain more proteins, there are fewer peptides that
map uniquely to one protein compared to the ZRP. This reduces of the effectiveness of the database for
shotgun proteomics, as correct peptide IDs are essentially lost due to the inability to distinguish between
multiple proteins.
Removing redundant proteins using cd-hit93 has a large impact on the rate of unique peptides greater
than length 7 (Figure 2.5a). For the FHMP, removing identical protein sequences increased the fraction
of unique peptide sequences by 10 percentage points, with almost no change in the quantity potential
tryptic peptides (Figure 2.5b). Allowing for inexact matches, by reducing the required percent identity,
showed diminishing returns beyond 90%. At that level approximately 70% of peptides greater than length
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(a) (b)
Figure 2.4: Comparison of frequency of unique peptides in the different protein databases. a) Fraction of
unique (single occurrence) potential tryptic peptides vs peptide size in the FHMP, U90CYP, and ZRP.
The dashed red line indicates a length of seven, a standard cutoff for minimum peptide size during peptides
searches. b) Number of possible peptides (unique sequences) and unique (single occurrence) peptides in
the databases.
7 are unique in the database, almost 30 percentage points higher than the original database. Uniqueness
is roughly equivalent to the U90CYP but still significantly behind the ZRP (Figure 2.4a).
Despite the greatly increased proportion of unique peptides, clustering at identity thresholds as low
as 85% had minimal effect on the total number of peptides (Figure 2.5b), and the distribution of peptide
lengths is unchanged (Figure A.1). BUSCO analysis of the database at various levels of clustering (Figure
2.6a) shows that the number of duplicated BUSCO genes is drastically reduced by removing similar protein
sequences, with almost half of duplicated BUSCO genes being removed when identical sequences are
clustered, and nearly two-thirds at 90% identity threshold. Despite the decrease in duplicated BUSCO
genes, there is almost no change in the number of complete BUSCO genes, with only 15 of over 3000
being lost between after clustering the database at 90% identity. Additionally, the number of proteins
in the database was reduced by 37%, removing over 21,000 protein sequences (Figure 2.6b) while the
number of unique peptides available increased by around 300,000 peptides (Figure 2.5b). Thus, removing
similar protein sequences by clustering with cd-hit significantly increases the number of proteins that can
be uniquely identified, but the overall set of tryptic peptides available for search has not been reduced,
and there is almost no loss in functional protein sequence.
Of the 37,454 proteins in the FHMP after clustering at 90% identity, 23,137 proteins are from the gene
predictions and the remaining 14,317 sequences are from the aligned transcripts. As the identity threshold
for clustering was lowered, the removed proteins were primarily from the transcript alignment (Figure
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(a) (b)
Figure 2.5: Comparison of frequency of unique peptides in the Fathead Minnow Predicted Proteome after
clustering a various identity thresholds. a) Fraction of possible tryptic peptides that occur only once in the
database vs. peptide size. Different lines indicate clustering at various identity thresholds. The dashed red
line indicates a length of seven, a standard cutoff for minimum peptide size during peptides searches. b)
Quantity of possible and uniquely occurring peptides after removing redundant proteins at various identity
thresholds.
2.6b). Since cd-hit retained the longest sequence during clustering, this suggests that transcript alignment
may not capture the full length of some genes, or that Augustus over-extends gene prediction. Investigating
difference between the gene predictions and transcript alignments may be a productive method for further
improving the FHM genome annotations.
Reducing redundancy has effects in addition to increasing the number of unique peptides in the
database. The majority of peptide search engines rely on a target-decoy strategy to distinguish cor-
rect and incorrect peptide identifications.52,77 There are two assumptions of the target-decoy method that
are dependent on database size and redundancy. First, the target-decoy method assumes effectively zero
overlap between the set of target and decoy peptides used in the search, an assumption which held true
for peptides greater than length 8 in the relatively small database of proteins used by Elias and Gygi
when they originally described the method.52 Second, it assumes that target and decoy peptides occur at
a known ratio, typically 1:1.52,58
There are a variety of methods for decoy generation in protein database, the most common of which
is protein reversal.97 However, many proteomics search engines, including the TPP and PEAKS, perform
pseudo-shuffling of protein sequences to generate a more random distribution of decoy peptides with similar
length and amino acid compositions. Since every protein sequence will be shuffled independently, duplicate
sequences in a redundant protein database will introduce multiple decoy peptide sequence for a single target






















Database Size after Clustering
(b)
Figure 2.6: Effects of clustering on FHMP size and completeness. a) BUSCO analysis after clustering
at various identity thresholds. i) ’Initial’ the original set of protein sequences identified during database
creation, ii-v) clustering at the indicated percent identity with cd-hit. b) Number of proteins in the
database after clustering at various identity thresholds. Color indicates is the protein sequence was derived
from an Augustus-predicted gene or from an aligned zebrafish transcript.
the target and decoy set and the chance of high scoring decoy hits. The impact of database redundancy
can be seen in Figure A.3, in which the Uniprot actinopterygii protein set was sub-sampled at various
fractions, and decoys were added before and after redundancy removal at 95% identity threshold. Despite
the larger number of proteins in the non-redundant database, there were fewer unique peptides, and the
overlap between the target and decoy peptide sets increases faster in redundant protein sets than the
non-redundant versions. Since the number of false positives and subsequent search statistics are estimated
from the number of high-scoring decoy hits,52 an inflated decoy peptide set can result in decreased search
sensitivity.57 Partly, this is because the FDR is calculated from a expected ratio of false positive target and
decoy peptide hits, i.e. is the ratio of target:decoy peptides is 1:1, the FDR at a given score threshold is
twice the number of decoy peptides passing the scoring threshold. However, change in the ratio of decoy to
target peptides can be accounted for when calculating FDR.52,58 The more significant issue is the increased
overlap between target and decoy peptides, as the target-decoy method assumes decoy hits are incorrect.
The FHM-specific Protein Database is Highly Unique
Though the FHMP contained fewer BUSCO genes than the ZRP and U90CYP, an in-silico tryptic digest
of the protein sequences (Fig. 2.7) shows that it contains a large fraction of peptides that do not occur
in the other potential databases. Most notably, the U90CYP protein databases contains a relatively small
proportion of peptides that are likely to occur in a tryptic digest of FHM tissue, with less than 25% of over
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Figure 2.7: Overlap of tryptic peptides longer than 7 residues found in a 6-frame translation of the FHM
genome, the U90CYP, and the FHMP. Circles are not weighted to peptide count.
1.5 million peptides being found in either the 6-frame translation or the FHMP tryptic peptide sets. As
can be seen in Figure 2.3a, BUSCO analysis showed a nearly complete set of genes, and the true fathead
minnow proteome most likely has orthologs to the vast majority of protein present in the U90CYP. The
low proportion of overlap is likely due to substitutions and indels accumulating in different species over
time, rather than the gain and loss of large numbers of proteins. Thus, despite likely representing a more
complete proteome than the FHMP in terms of the set of proteins present, the U90CYP contains fewer
correct peptides. Using the U90CYP for the search would result in the majority of spectra being searched
against peptides sequences with at least one incorrect residue. Since the search engines rely on matching
theoretical mass spectra to observed ones, incorrect residues reduce the score of spectra, reducing the score
of matched peptides.
The 6-frame translation of the FHM genome could be used as a database for peptides search, since
it would, by definition, contain the vast majority of possible tryptic peptide sequences found in proteins
29
encoded in the genome. However, Blakeley et al. [58] showed that databases using 6-frame translation of
genome sequences significantly reduced the sensitivity of protein identification, due to the inflation of decoy
peptides relative to the target database. This is related to the previously mentioned second assumption
of the target-decoy approach, that decoys occur at a known ratio to target peptides. The vast majority
of 6-frame peptides do not undergo translation, due to low gene density and minimal overlap of coding
regions.58,98 However, during creation of a decoyed database, peptides that do not actually exist in the
sample of interest still add to the number of decoys, since they also undergo shuffling or reversal. Similar
to decoy peptides, target peptides generated from sequences outside the coding regions cannot generate
true hits, only false positives. This increases the number of false positives, and thus the false discovery
rate, at a fixed score threshold. Adding extra peptide sequences that have little chance of being present
in the sample reduces the sensitivity of database search, and Blakeley et al. [58] suggest gene prediction
tools, including Augustus, as a method to combat database inflation. This issue is present, albeit to a
lesser extent, in the U90CYP as well.
Additionally, 26% of the peptides in the FHMP are not found in the 6-frame translation of the genome
at all. This is likely due to peptides spanning exon-exon junctions, as there are roughly 10 ‘non-genomic’
peptides for each protein, a little above the average of approximately 9 introns per coding genes found in
teleost genomes.98
Thus, while BUSCO analysis suggests that the FHMP is an incomplete representation of the true FHM
proteome, it is significantly more accurate than more complete protein databases, such as the U90CYP,
and better suited to database search than a 6-frame translation of the genome.
Protein Search Results comparison
To confirm that the FHMP performed better than the U90CYP and ZRP, proteins identification were
performed with the TPP using both Comet and X!Tandem search engines. Summary results of the search
can be found in Figure 2.8, and are consistent with the observed differences in the database. A total of
3,237, 3,190, and 3698 proteins were identified when using the U90CYP, ZRP and FHMP respectively.
While U90CYP is larger and more complete by both DOGMA and BUSCO metrics (Figure 2.2), 7455
(19.5%) more peptides, and 461 (14.2%) more proteins were identified when the FHMP database was used
to search the same data at the same FDR.
Database PSM score comparison
The increased protein identifications are due to a variety of factors. Figure 2.9 shows the distribution
of peptide-spectrum match (PSM) scores calculated by Comet after searching against the FHMP and
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Figure 2.8: Total size of the UniRef90 Cyprinidae Proteome (U90CYP), Uniprot Zebrafish Reference
Proteome (ZRP), and Fathead Minnow Predicted Proteome (FHMP) databases and the quantity of unique

































Comet PSM Score Distribution
Figure 2.9: Comet XCorr score distribution from the same mass spectrometry run after separate searches
against the decoyed FHMP (solid) and U90CYP (dashed) protein databases. The distribution of decoy
peptides scores is indicated in blue, and target peptide scores in pink. The vertical lines indicate the score
cut-off for an estimated 1% false positive (FP) rate in each distribution. The inset shows the estimated
FDR for the two different score distributions.
U90CYP databases for one mass spectrometry run containing 50,361 spectra. In both searches the total
number of matched spectra is similar, 48,688 for the FHMP versus 48,701 for the U90CYP. However,
while the distribution of target and decoy peptide scores follows a similar pattern for both databases, the
target peptide scores in the FHMP are more positively skewed than in the U90CYP. 660 more target
spectra were also identified when searching the FHMP than U90CYP, and the number of matching ions
and the total mass difference between theoretical and observed spectra were slightly higher and lower,
respectively (Table A.1). This suggests higher similarity between the experimental and theoretical spectra
when identifying PSMs, consistent with the expectation that the FHMP contains more accurate peptides
sequences based on the greater overlap in in-silico tryptic peptides (Figure 2.7).
The mean decoy peptide score was also slightly higher after searching the U90CYP than in the FHMP
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(Figure 2.9 and A.1). Since the score cutoff is calculated from the overlap between high scoring and
target peptides, increased decoy scores reduces the sensitivity of the search by increasing the required
score threshold for a given FDR. While the individual difference is small, the combined effect of decreased
target score and increased decoy score reduces the number of PSMs passing a 1% FDR cutoff. Despite
slightly more PSMs being generated when searching against the U90CYP, only 4052 PSMs exceed the 1%
FP score cutoff, while there are 5822 PSMs over the score cutoff after searching against the FHMP.
Since the U90CYP and FHMP were used for searching against the same mass spectrometry run,
the correlation in scores for particular spectra can also be compared. As expected, when the same target
peptide is identified from both databases, the Comet scores produced are identical (Figure 2.10a). Similarly,
when both databases produce a decoy hit, the resulting score is very similar, though the FHMP tends to
score slightly higher for the same scan (Figure A.4).
However, when the search engine identifies different peptides for the two databases for the same spectra,
the FHMP tends to score significantly higher. Figure 2.10b shows the score correlation when two different
target peptides are identified for the same spectra. For a portion of the hits, the score is essentially
identical, as in Figure 2.10a, likely due to the presence of peptide sequences with minor differences, such
as leucine to isoleucine variants, which produce indistinguishable or highly similar fragmentation spectra.
For dissimilar peptides the FHMP tends to score higher, and has more peptides passing the 1% FDR
score-cutoff, consistent with the higher accuracy expected from the FHMP.
The largest set of spectra was those in which a decoy peptide was identified from one database, and
a target peptide from the other (Figures 2.10c and 2.10d). The FHMP produces 1,866 more PSM identi-
fications from the target set than the U90CYP, and a greater proportion of the PSMs score over the 1%
FDR score threshold. However, there are still many high-scoring target PSM matches from the U90CYP
that don’t have a corresponding high-scoring match in the FHMP database (Figures 2.10b and 2.10d). In
these cases, the correct peptide sequence is likely missing from the FHMP as both the genome and the
annotations are incomplete (Figure 2.2a). Figure 2.7 also shows there are nearly 80,000 peptides sequences
that are present in both the U90CYP and the FHM genome but not present in the FHMP, suggesting that
more than 5% of the total set of peptides is missing. Since many of these spectra score over the 1% FP
rate score cutoff when searched against the U90CYP database, they may be biologically relevant peptides
that are not being identified due to the incompleteness of the FHMP.
Despite the number of potentially missing spectra, using the FHMP still produces more peptide and




Figure 2.10: Comparison of PSM scores between the FHMP and U90CYP databases, from the same mass
spectrometry run. a) PSMs with identical peptide sequences, b) PSMs which matched to different target
peptides in the different databases, c) PSMs that matched a target peptide in the FHMP and a decoy
in the U90CYP and d PSMs that matched to a decoy peptide in the FHMP and a target peptide in the
U90CYP. The number of PSMs in each plot are indicated above, the dashed diagonal line indicates the
1:1 ratio between scores, and the dotted horizontal and vertical line indicates the 1% FDR score cutoff for
the U90CYPand the FHMP, respectively.
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Table 2.2: Search method summary for the tools used.
Name Search Method
MSFragger Open-window database-spectra matching
Comet Narrow-window database-spectra matching
X!Tandem Narrow-window database-spectra matching
PEAKS 8.5 De novo spectra sequencing, database search
2.3.2 Search Engine Comparison
In addition to comparing different protein database sources, the effectiveness of different search engines
for identifying proteins and peptides from mass spectrometry data was compared. Search engines employ
different methods for identifying peptides from mass spectra, which are summarized in Table 2.2. Comet
and X!Tandem are both long-standing tools still commonly used for shotgun proteomics, which rely on
matching observed MS2 fragmentation spectra to theoretical spectra from peptides in a database.99,100 To
reduce the amount of theoretical fragment spectra to be searched, the precursor intensity from the MS1
spectra is used to select potential peptides for spectra search. MSFragger is a newer tool which uses novel
indexing of theoretical fragmentation patterns to improve the search speed, allowing orders of magnitude
increases in speed to search a wider range of theoretical spectra and increase the number of high scoring
peptide identifications.56. Finally, PEAKS 8.5 is a commonly used commercial software that performs de
novo peptide sequencing from the MS2 spectra and then performs a database search with the de novo
peptides to identify proteins.50
The total PSMs, peptides, and proteins identified by each tool from each sample can be found in
Table 2.3. With the exception of MSFragger, the number of PSMs per input spectra was highest in the
Trout sample, and lower in the Human and FHM searches. Generally, less than 50% of input spectra
will be matched to a peptide during database search.101 The Trout spectra acquisition was performed
on a Q-Exactive, while the other samples were both acquired on a Fusion Lumos mass spectrometer
in SPS mode (See Table 2.1). This means that the Trout MS2 spectra were generated in the higher
accuracy Orbitrap, rather than the lower accuracy ion trap.66 The Human and FHM samples traded lower
accuracy fragmentation spectra, which reduced the rate of PSMs identification, for more accurate reporter
ion spectra for quantification. However, despite the reduced number of spectra, the number of unique
peptides and proteins identified was higher in the Human sample, possibly due to the simpler extraction
and preparation methods for isolating protein from human cell cultures compared to fish liver samples.
In all datasets, Comet identified the largest number of proteins, and only lagged behind PEAKS for the
number of unique peptides in the Trout and FHM datasets where the protein database is less complete.
Generally, MSFragger performed the worst, falling behind the narrow-window search engines X!Tandem
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Table 2.3: Number of PSMs, peptides, and proteins identified by each search engine in each sample. For
PSMs the percentage of ID’d spectra is indicated in brackets.
Sample
Search Engine Human Trout FHM
PSMs
MSFragger 28,914 (20%) 11,965 (10%) 11,300 (8%)
Comet 36,936 (25%) 50,638 (41%) 14,450 (10%)
X!Tandem 32,377 (22%) 34,487 (28%) 15,584 (11%)
PEAKS 24,071 (16%) 51,527 (42%) 17,264 (12%)
Unique Peptides
MSFragger 18,632 3,211 2,853
Comet 23,604 11,786 3,592
X!Tandem 21,950 8,184 3,843
PEAKS 16,494 13,152 5,735
Unique Proteins
MSFragger 3,363 817 1,446
Comet 3,874 2,048 2,063
X!Tandem 3,549 1,636 1,963
PEAKS 2,084 2,010 1,902
and Comet in all cases. The poor performance of MSFragger is surprising, since the primary difference
between it and the narrow window search engines is not the method for identifying and scoring PSMs,
but the number of theoretical fragment spectra it compares to. As such, the search results should be at
worst relatively similar to the Comet and X!Tandem results. In the Trout dataset the performance of
MSFragger was particularly poor, identifying only 817 proteins and less than 1/5th the PSMs of PEAKS
and Comet. Given the higher accuracy of the spectra, this is contrary to both expectation and the results
of the other search engines. The relatively novelty and ongoing development of MSFragger at the time
of testing, and the inverse effect of spectra accuracy on the frequency of PSMs, suggests there may be
software modifications or setting specific to particular mass spectrometers or samples that need to be
adjusted to effectively identify proteins with MSFragger.
Since it is possible to incorporate search results from different software (e.g. with iProphet), the choice
of search engine is not limited to a single tool, but to the set of tools that are possible to combine. Since
the protein identifications were performed using the same protein database and spectra for each dataset,
the overlap in PSMs, unique peptides, and proteins could also be compared. Figures 2.11 and A.5 show
the degree of overlap within each set of features. Notably, all search engines identify a core set of proteins
comprising approximately 12 of all unique protein identifications. Additionally, each search engine identifies
a unique set of proteins that are not found by the other search engines (Figures 2.11c, 2.11d, and A.5e).
When searching the Human sample, for which the most comprehensive proteome is available, all
database-spectra matching tools outperformed the de novo PEAKS method, identifying up to 50% more
spectra and nearly twice as many proteins (Table 2.3). With a comprehensive and accurate set of proteins
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(a) FHM PSMs (b) FHM Unique Peptides
(c) FHM Unique Proteins (d) Human Unique Proteins
Figure 2.11: Upset diagrams of the overlap between a) FHM PSMs, b) unique peptide, c) protein IDs, and
d) Human Protein IDs). The vertical bar chart shows the size of each overlapping set indicated by the
circles underneath (e.g. in c), 192 identical proteins were identified MSFragger, Comet, and X!Tandem).
The horizontal bars indicates the total quantity of each feature identified by that search engine.
to match against, database search is simpler and more accurate, particularly with the lower accuracy mass
spectra produced from the ion trap. By contrast, in both the FHM and Trout samples, PEAKS identi-
fied the most PSMs and unique peptides. Comparing the overlap between the matched scan and peptide
sequence for the FHM (Figures 2.11a and 2.11b) and Trout (Figures A.5b, 2.11b) samples shows that
PEAKS de novo sequencing identified a large set of PSMs and peptides that the three database-spectra
matching tools could not identify, and a smaller set of unique proteins and peptides in Human samples
(Figures A.5a and A.5c. Since PEAKS doesn’t rely on the presence of the peptides in a database, the less
comprehensive proteomes available for Trout, and FHM in particular, weren’t as limiting on PSMs identi-
fication rates. Despite identifying more peptide sequences, PEAKS produced fewer unique proteins than
Comet in all samples, and only surpassed X!Tandem in the Trout sample. Since there is no corresponding
protein in the database, the unique peptides did not contribute to increased protein identifications.
This highlights both a strength and weakness of the PEAKS de novo method - while it is able to identify
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a large number of de novo peptides in the absence of a comprehensive database, the peptides still need
to be compared to some other set of sequences to identify proteins. While this could potentially identify
proteins not present in the original database, e.g. by BLAST search against a larger collection, calculating
FDR and quantifying expression become more complicated. Additionally, if searches are performed against
continuously updating online collections such as UniprotKB later replication of experiment results becomes
more difficult because the database may change between runs.
2.4 Conclusions
Due to the lack of a comprehensive protein database containing fathead minnow specific proteins, I have
described a method for database construction from genome sequence and predicted gene locations. This
database contains a set of peptides that are not found in Uniprot, and thus represents species specific
peptides more likely to be found in fathead minnows, while containing a significant proportion of the
gene sequences and protein domains that are expected in a ray-finned fish. The reduced database size
and redundancy has increased the sensitivity of mass spectrometry based protein identification using a
target-decoy method for FDR calculations.
The genome-derived protein database was assessed on the basis of single-copy orthologs, the set of
potential tryptic peptides, and the degree of redundancy within the database. BUSCO analysis showed that
the genome-derived database contained the majority of single-copy orthologs found in the genome. The set
of peptides derived from the genome predictions was a subset of those found in a 6-frame translation of the
FHM genome, and was similar in size in those found in the Zebrafish Reference Proteome. However, only a
small portion of the peptides were found in the U90CYP, indicating the protein database is species specific.
Finally, the initial database constructed was highly redundant, but clustering with cd-hit significantly
increased the fraction of unique peptides without significant effect on the set of potential peptides sequences
or predicted single-copy orthologs.
The genome-derived database is limited primarily by the quality of the gene predictions. Despite a large
number of aligned Zebrafish gene transcripts, the majority of the complete protein sequences are derived
from the Augustus gene predictions. While the majority of U90CYP tryptic peptides are not present on
the FHM genome 6-frame translation, there is still a significant number that are present, but missing in
the FHMP. Due to incomplete genome and annotations, the set of FHM protein sequences is incomplete
as well, and some biologically significant MS spectra may be missed during protein identification.
However, the FHMP still outperformed the U90CYP protein database for protein identification from
the same MS dataset. The FHMP produced more protein identification at the same error rate, and more
high quality PSMs and peptides.
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Comparison of different search tools showed that de novo sequencing identifies peptides and proteins
not found by spectra matching programs, but database-spectra matching tools generally perform better
when a comprehensive database is available. While PEAKS was able to identify more PSMs and peptides
in the FHM and Trout datasets, the lack of protein sequence information still prevented more proteins
from being identified. While de novo peptide information could be used for further protein identification, it
would increase the complexity of downstream analysis. This further highlights the importance of effective
database construction for protein identifications.
Comparison of the set of protein IDs from each search tool also showed that unique proteins were
identified from all search tools. This means that a single best search tool is unlikely to exist, and integrating
results from multiple search engines is important for achieving best coverage. For the purpose of analyzing
the FHM proteome for quantitative analysis, the Comet and X!Tandem search engines will be used, as both
can be integrated effectively with established tools, specifically, the Trans-Proteomic Pipeline (TPP).
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Chapter 3
Hepatic Proteome Analysis of
Fathead Minnows in the Bow River
3.1 Introduction
With an estimated 300-500L of wastewater generated per capita, per day in Canada, municipal wastewater
effluent (MWWE) is one of the primary sources for anthropogenic chemical compounds in aquatic envi-
ronments1. The resulting effluents are a complex mixture of chemicals, potentially including polyacyclic
aromatic hydrocarbons (PAHs), metals, pharmaceutical and personal care products (PPCPs), and a wide
variety of other contaminants. PPCPs in particular are of growing concern, as the efficacy of wastewater
treatment plants (WWTPs) in removing PPCPs can vary dramatically with treatment method and waste
source. Some pharmaceuticals may be resistant to degradation, causing them to persist in aquatic envi-
ronments11,102. PPCPs also encompass a wide variety of chemical compounds designed to be biological
active at low concentrations, and the effects of exposure on aquatic organisms is unknown2.
Metabolic changes in aquatic organisms have often been found after exposure to MWWE or its con-
stituent components. The liver is the site of a wide variety of lipid and glucose metabolism functions
important for energy regulation and mobilization.103 In fish, the liver can store up to 10-20% of total
body lipids and is the primary site for the synthesis of lipids and lipoproteins, making it an important
target for contaminants that affect lipid metabolism, such as statin and fibrate pharmaceuticals and
a wide variety of other organic pollutants.10,104,105 In particular, the peroxisome proliferator-activated
receptors (PPARs) regulate a wide variety of metabolic processes, such as fatty acid oxidation and elon-
gation, glucose metabolism, and lipogenesis.22 PPARs are known to be sensitive to exposure to a variety
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contaminants9 and peroxisome proliferation has been proposed as a biomarker for xenobiotic exposure.106
The liver is also a key site for biotransformation of xenobiotics, and is the primary site for expression of
cytochrome P450 isozymes, which target a wide range of xenobiotics for biotransformation and excretion.107
Biotransformation increases the oxidative stress the cell undergoes due to increased production of reactive
oxygen species in the peroxisome. The large number of processes for energy usage, stress response, and
homeostasis regulation taking place in the liver make it a key site for identifying potential biomarkers of
exposure to environmental contaminants.27,104
One known response to MWWE exposure is impairment of the cortisol mediated stress response in
fish, leading to a chronic stress condition.35,42 Cortisol regulates a variety of processes as part of stress
response by binding to glucocorticoid receptor (GR), a transcription factors which regulates a wide range
of processes.33 One of the primary targets of cortisol action is in hepatocytes, where it regulates a variety of
pathways to control energy usage during the stress response and maintain homeostasis. Cortisol signaling
in hepatocytes alters expressions of many energy related genes, such as phosphenolpyruvate carboxykinase
(PEPCK), a key enzyme in gluconeogenesis; as well as immune related genes such as suppressors of cytokine
signaling (SOCS) and Janus kinase-Signal Transducer and Activator of Transcription (JAKS-STAT) related
genes.14 Altering these functions is an important mechanism allowing fish to respond to stressors in the
environment and return to homeostasis.33
While many studies have investigate the impact of single contaminants on the liver, less has been done to
study impacts of chronic exposure on organisms in complex mixtures that occur in aquantic environments.12
Exposure to low levels of contaminants in complex mixtures can have a variety of interacting, often sub-
lethal effects, altering behavior and a wide range of biological functions in the organism, ultimately reducing
fitness.2,15 Studies of exposure to complex mixtures in natural environments often focus on reproductive
endpoints and impacts, but exposure to complex contaminant mixtures will impact a wide variety of
pathways, including metabolic and energy related pathways in the liver.12,42 While not directly lethal,
impacts on these function can reduce the ability of aquatic organisms to respond to stressors, negatively
impacting their fitness.35
The purpose of the study presented in this chapter was to investigate the changes that occur in the
hepatic proteome of fathead minnow (Pimephales promelas) caged in sites upstream and downstream of the
three WWTPs along the Bow River in Calgary, Alberta, Canada. This was performed as part of a larger
project investigating the impacts of MWWE exposure on stress response and reproductive health, the
mechanisms of it effects, and potential biomarkers for MWWE exposure. Shotgun proteomics and isobaric
mass tagging were used to identify changes in proteins between the different sites. Enriched pathways
and molecular functions were identified in the differentially expressed proteins, and gene set enrichment
analysis was used to compare expression profiles between sites.
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3.2 Methods
3.2.1 Exposure and Sampling
Field exposure and sampling was carried out alongside the field stress experiment described in Lazaro-Côté
et al. [12]. Briefly, a caging study in the Bow River, Calgary, Alberta, was carried out from September
to October 2016, using adult fathead minnows in 5 sites across the Calgary urban gradient (Fig. 3.1).
Two sites, Bearspaw Dam (BEAR) and Cushing Bridge (CUSH) are located upstream of the 3 WWTPs in
Calgary, and the other three, Glenmore (GLEN), Highway 22X (H22X), and Highwood River (UPHI) are
located downstream. Of the three WWTPs in Calgary, Bonnybrook produces the largest volume, releasing
4.5m3/s of MWWE, 8.3% of the flow of the Bow River. Fish Creek and Pine Creek are smaller plants,
releasing 0.4m3/s (0.6%)and 1.1m3/s (1.9%), respectively.12 All three WWTPs perform tertiary treatment
of MWWE, employing ultraviolet light for disinfection. Bonnybrook and Pine Creek perform biological
removal of nitrogen and phosphorous, while Fish Creek uses chemical treatment to remove phosphorous.108
While the BEAR site is located upstream of urban runoff, CUSH receives urban and rural runoff from
more than 100 storm water outfalls as well as Nose Creek. The GLEN site is located 15m downstream
of the Bonnybrook WWTP outflow, with minimal mixing, while H22X is 250m downstream of Fish
Creek WWTP, and H22X 18 km downstream of the Pine Creek outflow. Water quality parameters at
the sites can been seen in Table B.2. The mean water temperatures at the GLEN site (18.4 ◦C) was
significantly higher than all other sites (12.0–12.5 ◦C), and was conductivity was approximately 3-fold
higher (928.5 µS/cm compared to 298.3–397.4 µS/cm). Dissolved oxygen concentrations and pH were
significantly lower, 6.06mg/L and 7.23 compared to 9.63–11.04mg/L and 8.00–8.25, respectively.12
Adult fathead minnows were obtained from the University of Lethbridge, and acclimatized in-laboratory
to Bow River temperatures for two weeks. 35-36 adult fathead minnows were then randomly assigned to
each of the two cages at each site for 26 days. Galvanized steel minnow traps were used as cages, with a
150mm by 100mm piece of PVC pipe provided as shelter. Cages were cleaned every two days to avoid
obstruction of water flow through the cages, and no food was provided to the fish. Temperature, dissolved
oxygen, conductivity, pH, and turbidity were measured at each site prior to cleaning.
Following exposure fish were sacrificed and dissected on site on the day of collection between 9:30am
and 11:00am. A subset of 5-10 fish per cage (11-19 fish per site) were collected from each cage and sacrificed
by immersion in 1 g/L MS-222 buffered with sodium bicarbonate. Carcasses were weighed and the fork
length measured, then immediately dissected. Head kidney, gonads, and liver tissue were collected and
stored at approximately −80 ◦C. A total of 30 liver samples, 6 liver samples from each site, were used for
proteome analysis, with an overall sex ratio of approximately 1:1 (Table B.3).
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Figure 3.1: Locations of the 5 caging sites along the Bow River. WWTP locations are indicated by arrows
and the Calgary city limits are indicated in red.
3.2.2 Proteomic Analysis
Protein Extraction, Labeling, and Mass Spectrometry
Liver samples were processed using a modified version of filter aided sample preparation[109] previously
implemented in the McConkey Lab. Briefly, each sample was lysed in a buffer of 4% (w/v) SDS, 100mm
HEPES/HCl pH 7.6, 100mm 1,4-Dithiothretiol, and MS-SAFE protease inhibitor (Sigma-Aldrich Canada
Co., Oakville, ON, Canada, Catalog #MSSAFE-1VL). Samples were manually homogenized on ice using a
plastic pestle prewashed with methanol, then incubated at 95 ◦C for 5min, sonicated in 10 s pulses for 1min,
followed by another 5min incubation and 95 ◦C for 5min, and a 10min centrifugation at 14000x rcf to
clarify the extract. Proteins were then precipitated using a Calbiochem Protein Precipitation kit (Millipore
Canada, Etobicoke, ON, Canada, Catalog #539180-1KIT) following the manufacturers instruction, and
the pellet allowed to dry at room temperature for 5min. The pellet was then resuspended and solubilized
in 200 µL of 8m urea in 100mm HEPES/HCl pH 8.5 (UA) until completely resuspended.
Once resuspension had completed, protein was loaded into a Amicon Ultra 3kDa 1.5mL centrifugal
filter (Millipore Canada, Etobicoke, ON, Canada, Catalog #UFC500396) for digestion. Filters were washed
immediately before use with two volumes 500 µL of 60% methanol, then two washes with 500 µL of ultrapure
H2O. 100 µg of protein was added to each filter, and washed with 200 µL of UA, followed by a 20min
incubation with 200 µL of 50mm iodoacetamide. This was followed by three more washes with 200 µL of
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UA, then 3 washes with 200 µL of 100mm triethylammonium bicarbonate (TEAB). Proteins were digested
overnight at 37 ◦C with 0.2 µg/µL of trypsin/LysC (Promega, Madison, WI, Catalog #V5073), with tubes
wrapped in parafilm to reduce evaporation.
After digestion, peptides were eluted twice by adding 60 µL of 100mm TEAB to the filter, followed by
centrifugation at 30min at 14 000 rcf. Peptide concentration was measured using a Pierce Quantitative
Colorimetric Peptide Assay (Thermo Fisher Scientific, Rockford, IL, Catalog #23275) in triplicate. For
each sample run, 80 µg was transferred to a clean microfuge tube, and the sample volume adjusted to
100 µL. Tandem Mass Tags (TMT) labeling was performed according to manufacturer’s instructions, with
labels randomly assigned to each sample in the run. Samples were then combined into one tube and dried
under a vacuum, then stored at −20 ◦C prior to mass spectrometry analysis.
Mass Spectrometry
Samples were sent to the SPARC BioCentre Molecular Analysis facility for mass spectrometry analysis on
the Thermo Orbitrap Fusion-Lumos in SPS (MS3) mode. Three separate mass 1 hour spectrometry runs
were performed, each containing 10 different samples, two from each site.
3.2.3 Protein Identification
Database Construction
Due to lack of a fathead minnow-specific protein database, fathead minnow genome sequence data59 was
downloaded from the SETAC website85, along with annotations for Augustus-predicted gene sequences and
aligned zebrafish transcripts with corresponding Ensembl IDs.60 Protein database construction is described
in detail in Section 2.2.1. Before searching, randomized decoy proteins were added to the database using
the Trans-Proteomic Pipeline (TPP) decoy generation script95.
Database Search
RAW data files were converted to mzML using ProteoWizard110. Database searches were performed using
Comet55 and the TPP-specific X!Tandem95 against the previously described Fathead Minnow Predicted
Proteome (FHMP) database, with added randomized decoy proteins. For both search engines, the enzyme
was set to trypsin, with one missed cleavages allowed for each peptide. Oxidation of methionine was set as
a variable modification, and carbamidomethylation of cysteine and the TMT balance tag of 229.1629 on
N-terminal and lysine residues as static modifications. Ions in the m/z range of 125 to 132 were ignored to
prevent TMT reporter ions from being included in the peptide identification. Monoisotopic masses were
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used for the search for both peptide and fragment ions, with a mass tolerance of 15 ppm for the parent
peptide and 0.6Da for the fragment.
PeptideProphet51 was then used to assign confidence scores to the peptide IDs in each run. Results
from each search engine across the three runs were integrated using iProphet53, and protein IDs and groups
were assigned and given a confidence score using ProteinProphet54. The minimum protein probability was
set at 0.7552, equivalent to an estimated false discovery rate (FDR) of 1%.
3.2.4 Differential Expression Analysis
Protein Normalization and Quantification
TMT reporter ion intensities for each peptide-spectrum match (PSM) were identified using the TPP Libra
module95 individually for each mass spectrometry replicate. The full set of PSMs, along with confidence
scores, raw reporter ion intensities, and the ID of the originating protein were exported from the TPP web
user interface to a text file. Additionally, protein IDs from all protein groups identified at an FDR of 1%
were also exported. A custom python script (Appendix B.2) was then used to filter the PSM list to remove
all peptides that matched to multiple proteins. As part of filtering, the genomic region of proteins that
matched an identical set of peptides were compared, and any proteins that matched to the same sequence
scaffold with greater than 50% overlap were considered to be duplicate identifications of the same protein,
and only ID of the longest sequence was used for filtering. Next, an in-house R script (Appendix B.1)
was used for further filtering of PSMs, as well as quality control, normalization, and differential expression
analysis. All PSMs with an iProphet confidence score less than 90% were discarded. Multidimensional
scaling and of the peptide-level log-transformed intensities distributions were visualized with R111 and
ggplot2112 to compare sample similarity and intensity distributions.
Next, for each mass spectrometry run, PSMs with fewer than 2 unique TMT reporter ions were dis-
carded. A list of housekeeping genes identified from RNAseq data in human samples was matched to
zebrafish symbols, and all then mapped to the fathead minnow (FHM) protein IDs. All identified PSMs
matching to proteins from the housekeeping list were correlated across samples using Pearson correlation
to identify potential outlier samples. The reporter ion intensity for all peptides of the same protein were
summed, and normalized across the whole run with the limma113 justvsn function (Appendix B.3). The
number of PSMs and unique peptide sequences for each protein was recorded. The Pearson correlation of
protein expression across all samples for protein in the housekeeping list was calculated, then the median
expression for each protein was subtracted from each sample. All proteins with less than 2 unique peptide
sequences were dropped from the list for each run. Finally, the protein-level quantification data was then
merged by protein ID, and any proteins not present in all of the three runs were removed. Multidimensional
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scaling and intensity distribution were calculated on the normalized protein log-fold change expression.
Differential Expression
Differential expression analysis was carried out with the R package limma. A model matrix was specified
with a coefficient for each site, as well as the sex of each sample as a blocking factor. The duplicateCorrelation
function was used to calculate correlation between biological replicates in the different mass spectrometry
runs, and the expression data was fit to a linear model for each protein. The 5 sites were divided into
three groups: Upstream, consisting of BEAR and CUSH; Outflow, the GLEN site; and Downstream, the
H22X and UPHI sites (Fig. 3.2). Contrasts were created to compare the three groups, and the differential
expression was calculated using empirical Bayes within limma. Proteins were considered significant with
a p-value cutoff based on a 5% FDR calculated using the method of Benjamini-Hochberg114, with multi-
ple testing correction performed on all contrasts combined using the ’global’ method of the decideTests
function.
Figure 3.2: Grouping of the caging sites for differential expressions analysis. Green circle: Upstream
Group, containing sites BEAR and CUSH, red circle: Outflow group, containing the GLEN site, yellow
circle: Downstream group, containing the H22X and UPHI sites.
Following differential expression analysis, protein annotation information was collected from on-line
resources to to better determine what proteins were differentially expressed (DE), and their putative
function. Ensembl94 IDs for each protein were searched using the R biomaRt package115, and the gene
description and GO terms associated with each gene automatically downloaded and annotated to the
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protein. The proteins were then identified in the ZFIN database116, and the ZFIN gene name was recorded
for each gene. Known or predicted interactions between DE proteins were visualized into Cytoscape using
StringApp117.
Molecular Function Enrichment Analysis
Once gene symbols were identified for all the differentially expressed genes, the Ensembl Danio rerio tran-
script id was downloaded for each gene and compiled into a list. The transcript list was uploaded to the
DAVID118,119 functional annotation tool as a gene list with the ZFIN gene name as the identifier. The
genes were searched for molecular functions that enriched in a statistically significant manner compared
to their occurrence in the background protein list, with Danio rerio as the background gene set. The func-
tional annotation chart produced by DAVID was downloaded and imported into the R FGNet package120,
which groups genes with molecular functions identified by DAVID as statistically enriched into overlapping
clusters of shared molecular function. This allows for easier identification of particular molecular functions
within the tissue sample that are changing, allowing the analysis of changes beyond the effects of single
genes.
Gene Set Enrichment Analysis
Gene Set Enrichment Analysis (GSEA)121 was performed with the normalized protein expression data
for all samples. Samples were assigned phenotypes according to sampling site groups (Figure 3.2). Gene
set for GO122 Molecular Functions and Biological Process, and Reactome123 pathways were scored for
enrichment for the Outflow group vs the Upstream group, and the Downstream group vs the Upstream
group. Cytoscape124 was used to visualize enriched gene sets with an enrichment score cutoff based on a
20% FDR from either comparison.
3.2.5 Contaminant Concentration Measurements
Measurement of select PPCPs was described in previously in Lazaro-Côté et al. [12]. Water contaminant
levels were averaged according to the group used in the analysis.
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3.3 Results and Discussion
3.3.1 Fish morphometrics and mortality
The survival rate of the caged fish was 93.0% at BEAR, 90.1% at CUSH, 100% at GLEN, and 70.4% for
both H22X and UPHI. Generally, survival rate was consistent the between cages at different sites, with
the exception of UPHI, where the majority of losses occurred in one cage.108 For fathead minnows used in
proteome analysis, there was significant differences in the condition factor (F(4,25) = 4.7831, p = 0.0053)
between sites, but no significant differences in fish mass (F(4,25) = 1.5201, p = 0.2267) or fork length
(F(4,25) = 0.7425, p = 0.5721) (Table B.3). Condition factor at the CUSH and GLEN sites was significantly
higher than at the BEAR site, but not H22X or UPHI. No other significant differences between sites were
found. Analysis by Lazaro-Côté et al. [12] of all 165 fish caged as part of the larger study, including the
ones used for proteome analysis, did find that fish mass and fork length was significantly higher at the
GLEN site compared to the other sites. Condition factor was also significantly different, higher at CUSH
compared to all sites except GLEN, and higher at GLEN than at BEAR and UPHI.
Due to the limited number of fish available from the study, an even sex ratio was not possible for all
sites. While CUSH, GLEN, and H22X had an equal number of male and female (3/3) fish, BEAR and
UPHI had more male fish, 2/4 and 1/5, respectively. For the groups used for analysis, the ratio (F:M) was
5:7 in the Upstream group, 3:3 in the Outflow group, and 4:8 in the Downstream group.
3.3.2 Proteins identified from FHM genome annotations
For database construction, 36,911 ZFIN transcript alignments and 43,345 predicted gene sequences were
present in the FHM genome annotations. After translation, a total of 62,707 protein sequences were
identified; filtering redundant proteins at 90% identity with CD-HIT reduced the total database size to
37,454 putative protein sequences.
3.3.3 Run results
The database search of the three MS runs identified a combined total of 3,698 proteins with two or more
peptides in any of the three runs, using an estimated FDR of 1%. From the 91,524 total PSMs identified
during database search, 36,722 have an iProphet confidence score greater than 90% and uniquely match
to one high-confidence protein. The distribution of Log2-transformed intensities is relatively consistent
across runs, with a mean Log2-intensity of approximately 13 and interquartile range between 10 and 15
for most samples (Figure 3.3).
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Figure 3.3: Distribution of Log2-transformed PSMs intensities. Samples are sorted by mass spectrometry
run (A-C), then caging site and cage number, as indicated in the sample label at the bottom. Color and
line style indicate the caging site and sex of the sample, respectively.
In the second mass spectrometry run (run B), 1 sample (BEAR.B.1.F) shows an interquartile range
starting at zero, indicating that a large number of PSMs had no reporter ions in that sample; additionally,
the mean intensity is lower than other samples. Comparison of the total reporter ion intensity for the
different runs (Figure 3.4) shows that while the number of ions reported for that sample was comparable
to samples in other runs, two other samples in the same run have elevated reporter ion intensities. These
samples would likely have been present in the run at a higher ratio than other, causing them to ’crowd-
out’ the other samples and causing underreporting of the samples. Alternately, the higher abundance
samples may have more low-abundance peptides detected, increasing the number of zero-intensity peptides
in other channels. However, discarding all PSMs with fewer than two TMT reporter ions recorded did
not noticeably reduce the total ion intensity of any samples (Figure B.1), suggesting that increased low-
abundance peptides from over-represented samples is not responsible for the missing reporter ions from
samples BEAR.B.1.F.
Intra-run correlation of peptide intensities between samples for the list of 226 housekeeping genes
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(a) (b) (c)
Figure 3.4: Sum of reporter ion intensity for the 10 reporter tags in each of the 3 mass spectrometry runs.
Table 3.1: Number of PSMs in the three runs at various stages of filtering.
Run Total PSMs High Confidence >2 Reporter Ions
A 31,015 12,111 10,461
B 30,575 12,529 11,045
C 29,934 12,082 10,339
was high for all runs, with a minimum Pearson correlation of 0.89 for any pair of samples(Figure 3.5).
Overall, the different mass spectrometry runs produced similar results, with consistent quantities of PSMs
at different stages (Table 3.1) and all samples producing total reporter ions within a 3-fold range (Figure
3.4.
3.3.4 Normalization
After filtering, the PSM reporter ion intensities were summed by protein and normalized by variance stabi-
lized normalization (VSN) within each run individually. Pearson Correlation of expression of housekeeping-
proteins was similar between samples, ranging from 0.92 to 0.99, with the exception of sample H22X.C.2.M
in run C, which had correlation scores between 0.88 and 0.94 (Figure B.8). The log fold change of protein
expression also had a larger interquartile range and wider distribution than other samples in the same
run (Figures B.9 and B.10). Multidimensional scaling (MDS) grouped samples by site but with sample
H22XC.2.M as a clear outlier from the rest (Figure B.11). Finally, a heatmap clustering the samples by
similarity of expression places the H22X.C.2.M sample as a clear outlier from all other samples (Figure
B.12). The H22X.C.2.M sample is considered to be an outlier and was excluded from differential expres-
sion analysis. Since the removed sample was male, the ratio of females to males (F:M) change to 5:7, 3:3,
and 4:7 in the Upstream, Outflow, and Downstream groups, respectively.
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Figure 3.5: Intra-run correlation of PSM reporter ion intensities for mass spectrometry run A. Figures for
runs B and C are in Appendix B.3
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Filtering and normalization analysis were performed on the run C samples again, with the H22X.C.2.M
sample excluded. With the outlier removed the correlation between housekeeping-protein expression with
samples was consistently 0.92 or greater in all runs (Figure 3.6, and Figures B.4 and B.5 in Appendix B.3).
The most heavily effluent exposed site, GLEN, has the greatest deviation from the two upstream sites,
BEAR and CUSH, with UPHI placed in between. The H22X site, even after the removal of the outlier
sample, is less strongly grouped than other sites, and overlaps the BEAR, CUSH, and UPHI groups. While
the samples are separated by site, there is no clear separation of samples by other factor, such as sex, or
cage. The significant overlap between the BEAR and CUSH groups, and the dispersion of the UPHI group
support the decision to group multiple sites together for analysis. (Figure 3.7).
3.3.5 The Hepatic proteome is altered downstream of WWTPs
For differential expression analysis, a total of 895 proteins were identified in all three runs by at least
two unique peptides. 164 proteins were identified as differentially expressed in at least one of the three
comparisons. Of those, 140 proteins were DE between the Upstream and Outflow groups, and 23 proteins
were DE in the Downstream group compared the Upstream group. Finally, 92 protein were DE between
the Outflow and Downstream groups. The overlap in differentially expressed proteins between comparisons
can be seen in Appendix B.7. The full list of DE proteins is shown in Table 3.2.
Clustering of samples by expression level of DE protein (Figure 3.8) shows a similar pattern to Figure
3.7. The GLEN site samples forms a cluster with similar expression pattern showing clear differences from
other sites. The CUSH, BEAR, H22X, and UPHI site samples are less clearly distinguished, however, the
H22X and UPHI site samples tend to cluster together, as do the BEAR and CUSH sites. The expression
changes in the BEAR and CUSH are also more strongly contrast the GLEN sites changes, while H22X
and UPHI are more similar. There are no clear patterns of clustering by other factors such as sex or cage.
Pathway enrichment analysis of the differentially expressed proteins in the Outflow site (Figure 3.9)
revealed that differentially expressed proteins at the outflow site were significantly enriched for lipid and
amino acid metabolism, drug and xenobiotic metabolism, and RNA splicing functions (Figure 3.10). The
Downstream group, with fewer DE proteins, had only four enriched pathways, comprised of amino acid
and purine metabolism, drug metabolism, and spliceosome relate proteins. While differential expression
in the proteome compared to the upstream groups was highest in the Outflow group, in the 18 proteins
found differentially expressed in both the Outflow and Downstream groups, all proteins agree in direction
of changes, and the magnitude of change is consistently reduced in the downstream group (Table 3.2).
Additionally, three of the four KEGG pathways enriched in the Downstream group are also enriched at
Outflow group (Figure 3.9). This suggests that there is a similar effect, but with reduced magnitude,
52
Figure 3.6: Intra-run correlation of normalized protein intensities for mass spectrometry run C. Figures
for runs A and B are in Appendix B.3
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Figure 3.7: MDS plot of normalized protein Log2 fold-change. The label next to each point indicates which
of the three mass spectrometry runs (A-C), sample cage (1 or 2), and the sex (M or F) of the sample.
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Figure 3.8: Heatmap of samples clustered by differential expression pattern. Sample naming follows the
same scheme as Figure 3.7.)
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(a) (b)
Figure 3.9: Enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in significantly dif-
ferentially expressed proteins in a the Outflow group and b the Downstream group. Only the top 15 most
enriched KEGG pathways are show in figure a. The size of each node indicates the number of proteins
with that term, and the color indicates the Benjamini-Hochberg adjusted p-value for the enriched term.
occurring in the Downstream group (H22X and UPHI sites) and the Outflow group (GLEN site). For
comparison, measurement of select PPCP found they were mostly indetectable upstream of the WWTPs,




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.10: Network of DAVID Functional Annotation Cluster from significantly differentially expressed
proteins in the Outflow group. The size of each node indicates the number of proteins with that term, and
edges indicate overlapping groups. Edge thickness is proportional to the Jaccard similarity of the groups.
3.3.6 Differentially expressed proteins in the Outflow Group
Further analysis of the Outflow group using DAVID for a combined analysis of GO, KEGG, and Reactome
terms showed that the DE proteins had range of molecular functions (Fig. 3.10, Table 3.2) consistent with
a general xenobiotic stress response. Of particular interest, Figure 3.10 shows that a large group of proteins
with overlapping oxidoreductase, and Cytochrome P450 functions was upregulated. This is consistent with
exposure to a wide range of different contaminants, which induce metabolic changes and increased oxidative
stress in the organism in order to biotransform xenobiotics for inactivation and removal125. In addition,
proteins with PPAR signaling and carbon metabolism molecular functions were also significantly enriched
compared to the upstream group. PPAR signaling regulates many metabolic functions, particularly lipid
metabolism, which plays a key role in maintaining energy homeostasis in fish10. Common pharmaceuticals,
including statins and fibrates like gemfibrozil, which have previously been found in the Bow River11 as
well as a part of this study (Table B.1), are known to impact PPAR signaling and lipid metabolism in
environmentally relevant exposures.10,21 However, the increased nutrition in the WWTP outflow,12 along
with the increased temperature, (Table B.2) may play a significant role in the observed changes in the
Outflow group.
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Phase I Xenobiotic Metabolism
A variety of proteins are commonly found in the response to xenobiotic challenge, usually involved in Phase
I or II biotransformation, or combating the oxidative stress induced by degrading these compounds27. A
key type class of protein for the transformation of xenobiotics is the cytochrome P450s, heme-binding
enzymes that catalyze mono-oxygenase reactions on both exogenous and endogenous chemicals.26 While the
commonly used biomarker CYP1A proteins were not differentially expressed in any of the comparisons, a
range of CYP2, 3, and 4 family proteins were significantly differentially expressed. Cytochromes are diverse
in function, with families one through four are generally considered as having xenobiotic metabolizing
function29. Previous studies in medaka have found that family two cytochrome P450s are widely regulated
in response to exposure to benzo[a]pyrene126 and water-soluble crude oil components.127
CYP2AA4 was the most strongly upregulated protein Outflow group, with a 31.9-fold increase in ex-
pression (Table 3.2). The CYP2AA family is most similar to the CYP2X family, and is fish-specific. The
function of the CYP2AAs if unknown, previous test have suggested that the CYP2AA family may respond
to phenobarbitol-type inducers.128 CYP2X10.2 was the second most strongly differentially expressed pro-
tein in the Outflow groups, showing a log2FC of 4.76, and the most strongly differentially expressed in
the Downstream group, with a log2FC of 1.79 (Table 3.2). The CYP2X family is found in fish but not in
mammals29, and limited information is available regarding their function. Studies of the CYP2X1 protein
in channel catfish found limited similarity in function and substrate specificity to other CYP2 family pro-
teins129. However, studies of goldfish have found upregulation of CYP2X10 in fish exposed to wastewater
effluent. Interestingly, the study compared fish in two lakes, and upregulation occurred in the lake that
was both exposed to municipal wastewater effluent and experienced increased temperatures of 5-10 ◦C over
the ambient temperature130, similar to what was observed at the GLEN site (Table B.2). This suggests a
potential link between the expression of CYP2X10 and temperature.
Five other CYP proteins, CYP2AD2, CYP2K21, CYP3C4, CYP4T8, and CYP51 were also differen-
tially expressed in the Outflow Group compared to Upstream. CYP51, a key enzyme in the synthesis of
cholesterol,26 was downregulated, while the remaining were upregulated.
CYP2AD2 is part of a cluster of family 2 cytochromes occurring next to the conserved HOOK1 gene that
have undergone expansion in Danio rerio into the CYP2N, CYP2P, CYP2AD, and CYP2V subfamilies,
compared to the single CYP2J2 found in humans29. This expansion has also been found multiple species
of killifish28,131, and can also be partially observed in the fathead minnow genome. While the specific
function of all these cytochromes are not known29, CYP2J2 in humans is an epoxygenase that converts
arachidonic acid into epoxyeicosatrienoic acid (EET) and other signaling molecules involved in regulation
of apoptosis, inflammation, and metabolism through interaction with PPARs132; the CYP2N subfamily
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in F. heroclitus has been shown to have a similar function131. The CYP2AD2 and orthologs have also
been found to be xenobiotic responsive, being increased expression in response to bisphenol A (BPA), and
4-octylphenol (OP)31, and has been shown to degrade benzamphetamine in killifish131.
Fish CYP4s are thought to be fatty acid hydroxylases like their mammalian orthologs, and to play
a smaller role in xenobiotic metabolism.29 However, exposure to clofibrate and other PPAR inducer has
been known to alter expression of CYP4T8 orthologs and impact fatty acid hydroxylation in some species,
suggesting a link between CYP4s, fatty acid metabolism, and xenobiotics.26 The functions of the remaining
DE￿CYPs, CYP2K21 and CYP3C4, are unknown.26,29
Besides the cytochrome P450s, several other proteins involved in xenobiotic metabolism were differen-
tially expressed. Aldehyde oxidase 6, AOX6, is upregulated nearly 4-fold, and has broad substrate speci-
ficity for the oxidation of various drugs in concert with different P450 enzymes as well as monoamine-oxidase
(MAO),133 which was upregulated more than 2 fold. Another potentially interesting set of non-CYP450
proteins for xenobiotics degradation is the combined upregulation of DHDHL and COMTA. DHDHL,
or dihydrodiol dehydrogenase (dimeric) like, an ortholog of the human DHDH protein116, is upregulated
4.7-fold. DHDH oxidizes polycylic aromatic hydrocarbons to catechols.134 Catechol-O-methyltransferase a
(COMTA) is also upregulated in the Outflow group, and degrades neurotransmitters and other catechol-
based chemicals, including a wide variety of drugs, through methylation.135 This may indicate the use of
two sequential modifications of a xenobiotic to maximize chances of inactivation and removal.
Notably, the four most strongly differentially expressed proteins between the Upstream and Outflow
groups are CYP2AA4, CYP2X10.2, DHDHL, and AOX6, suggesting a significant demand for increased
xenobiotic metabolism. The large change in CYP2 family protein expression, particularly CYP2X10.2,
suggests their potential as a biomarker, however, the quantity and variety of the CYP2s in fish, and the
variability of their response to xenobiotics26,29,31 suggests that selecting any particular CYP2 for testing
would be difficult.
Phase II Xenobiotic Metabolism, Oxidative Stress, and Glutathione Metabolism
The glutathione S-transferases (GSTs) MGST1.1, GSTP1, GSTA.2, and GSTO1 were also upregulated
between 1.7 and 2.2-fold. GSTs are important for xenobiotic removal because they catalyze the conjugation
of reduced glutathione (GSH) to diverse compounds to reduce activity and increase solubility of the
compound for excretion. GSTP1, GSTA.2, and GSTO1 are cytosolic GSTs that also function as GST
peroxidases, removing reactive oxygen species (ROS) to prevent oxidative damage.136
A side effect of biotransformation of xenobiotics is increased ROS,133 and several oxidative stress pro-
teins were found to be significantly upregulated in the Outflow group. In particular GPX4A, glutathione
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peroxidase 4a, and PRDX6, peroxiredoxin 6, both have known antioxidant behaviour. Glutathione peroxi-
dases play an important role in removing H2O2 by catalyzing the formation of dimeric glutathione (GSSG)
from the reduced form (GSH), simultaneously converting hydrogen peroxide into water, and glutathione
peroxidase 4 (GPX4) is a well characterized GPx known to protect against oxidative attack on lipids.27,137
In their review of redox regulation in peroxisomes, Walker et al. suggest that, due to the inactivation of
catalase when exposed to elevated levels of hydrogen peroxide, glutathione peroxidases may be the pri-
mary mechanism for H2O2 during acute oxidative stress, such as exposure to hypolipidemic drugs such as
fibrates or statins.32 Peroxiredoxins also play an important role in oxidative stress32, but PRDX6 proteins
are unique in having both peroxidase and phospholipase activity, allowing them to protect phospholipids
in lipid membranes against the oxidation by preventing the formation of damaging hydroperoxides.138. In
the Outflow group, GPX4A showed a 2-fold increase in expression, and PRDX6 a 1.7-fold increase (Table
3.2), suggesting increased need for antioxidants in the fish at the GLEN site.
In addition to the enzymes to catalyze ROS and xenobiotic transformations, maintaining sufficient levels
of GSH is necessary for maintaining ROS homeostasis. CBSA, cystathionine-beta-synthase a, performs
the first step in the conversion of homocysteine to cysteine for glutathione and protein production and
was upregulated 2.4-fold.139 GSSG can also be reduced by to GSH by NADPH, which is catalyzed by
glutathione reductase (GSR). NADPH is itself regenerated by phosphogluconate dehydrogenase (PGD)
and glucose-6-phosphate dehydrogenase (G6PD).140 PGD was significantly upregulated, while the GSR
and G6PD were upregulated, but not significant (Table 3.2 and Figure B.13). This demonstrates an
increase in both the proteins to carry out xenobiotic and ROS reactions, and proteins producing the
necessary endogenous compounds for those reactions. Field studies of MWWE have found changes in
oxidative stress proteins after exposure,20,130 and changes in glutathione and oxidative stress parameters
has been widely studied as a biomarker for a wide variety of contaminants, including metals,27 polycyclic
aromatic hydrocarbons and other organic pollutants125, and MWWE exposure.141 However, response of
oxidative stress proteins and glutathione metabolites is usually highly variable with species, contaminant,
dose, and degree of exposures.27,142
Changes in Lipid Metabolism and the Tricarboxylic Acid Cycle
A number of genes related to lipid metabolism were DE in the Outflow group compared to the Upstream
group. Multiple peroxisomal β-oxidation proteins were significantly upregulated, including the acyl-CoA
oxidases, acyl-CoA oxidase 1 (ACOX1) and ACOX3, by 1.8-fold and 1.5-fold, respectively, as well as
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase (EHHADH) by 1.5-fold (Table 3.2. ACOX1,
also known as palmitoyl acyl-CoA oxidase 1, is responsible for beta-oxidation of long-chain fatty acids in
the peroxisome, while ACOX3, along with EHHADH, are part of the degradation pathway for branched-
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Figure 3.11: Search Tool for Retrieval of Interacting Genes/Proteins (STRING)143 interaction network of
significantly differentially expressed protein in the Outflow group. Nodes are coloured by Log2 fold-change,
and the outer rings indicate enriched pathways for select genes. Edges between nodes proteins with known
or suspected interactions.
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chain fatty acids.10 SLC27A2b (solute carrier family 27 member 2b) was upregulated 1.7-fold, and converts
fatty acids imported into the peroxisome into acyl-CoA for β-oxidation.144 ACOX activity in the perox-
isome is a known marker of β-oxidation in the peroxisome, and is a rate limiting step, though ACOX
activity and gene transcription are known to be disconnected.9 Both of these processes produce hydrogen
peroxide as a byproduct, increasing the oxidative burden on the organism,32 which may be linked with the
increased expression of GPX4a and PRDX6, and the various GSTs. Acyl-CoA oxidase activity has has
been previously suggested as a possible indicator of fatty acid (FA) metabolism changes after exposure
for a variety of compounds in aquatic environments, including fibrates and perfluoroalkyl acids.10 Other
proteins involved in peroxisomal β-oxidation are also upregulated. However, the changes observed in lipid
metabolism and oxidative stress are consistent with differential expression of genes with increased food
availability,145, which is expected with the increase nutrient downstream of MWWE outflow.
Other proteins differentially regulated in the Outflow group are also linked to lipid metabolism.
Apoliprotein A-II (APOA2), which is involved in transport of lipids, as well as retinol binding protein
7b (RBP7b), which is both activated by and a co-activator of PPARγ,146 were upregulated. GOT1 (in-
creased 1.5-fold) is the cytoplasmic variant of glutamic-oxaloacetic transaminase, which is necessary for
the regeneration of the peroxisomal NADPH needed for peroxisomal β-oxidation. Also upregulated was
the protein carnitine O-octanyltransferase (CROT), part of the export pathway of shortened FAs from
the peroxisome to the mitochondria via carnitine shuttling144. Interestingly, while CROT is upregu-
lated nearly twofold in the Outflow group, a carnitine biosynthesis protein, aldehyde dehydrogenase 9a1b
(ALDH9A1B) was downregulated. Given the evidence of increased peroxisomal fatty acid oxidation, in-
creased carnitine biosynthesis would be expected, though aldh9a1b downregulation has been observed with
long term exposure to mixtures of persistent organic pollutants.147
An important regulator of lipid metabolism is the PPAR signaling pathway, particularly through
PPARγsignaling. PPARγis known to regulate expression of ACOX1, along with a variety of other other
proteins, to increase rate of fatty acid oxidation (FAO) in the peroxisome for energy utilization and FA
elongation. PPAR transcription factors are activated by a wide variety of ligands, such cellular lipids
and phospholipids, as well statins, fibrates, and a wide range of organic pollutants.10 For example, the
EET created from arachidonic acid by CYP2J2 homologs,131 is a known agonist of PPARs148, as are
polyunsaturated fatty acids (PUFAs) created during FA elongation.149 Expression of arachidonic acid and
many of the signaling molecules derived from it are altered by ROS levels,150, and many be degraded
by lipid peroxidation under oxidative stress.151 With increased lipid metabolism there may be increased
need for production of these signaling molecules and reversal of oxidative damage, such as performed by
PRDX6. However, as with the increase ACOX expression, the changes in APOA2, RBP7b, and CROT
are consistent with changes in PPAR and FA metabolism expected with increased nutrients.145
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Metabolic protein expression changes beyond fatty acid β-oxidation were also observed in the Outflow
group, including proteins involved in the tricarboxylic acid cycle (TCA) and related pathways. Citrate
synthase (CS), which regulates entry of acetyl-CoA into the TCA and influences lipid and cholesterol
synthesis,152 was downregulated 1.5-fold, and MPC2, a protein necessary for the import of pyruvate
into the mitochondria for oxidation153 was down-regulated 2.9-fold. SLC25A1B, a mitochondrial citrate
transporter, and acyl-CoA dehydrogenase, very long chain (ACADVL), a mitochondrial beta-oxidation
protein,10 were down-regulated well, as was ATP5O, a mitochondrial ATP synthase(Table 3.2). Combined,
the downregulation of these protein suggest reduce β-oxidation and TCA activity in the mitochondria of
fish in the Outflow group.
Cholesterol synthesis and transport was also altered the Outflow group. As previously mentioned
in Section 3.3.6, CYP51 was downregulated 2-fold, additionally, farnesyl diphosphate synthase (FDPS),
was downregulated 1.7-fold, along with ABCD11B, down 1.5-fold. CYP51 and FDPS are necessary for
the synthesis of cholesterol.154,155 ABCB11B is a bile salt exporter pump, performing the rate-limiting
step in excreting cholesterol and cholesterol metabolites along with various toxic lipophilic substances,
and allowing for the digestion of various fats and vitamins in the intestine.154 Cholesterol and bile acid
synthesis processes rely on products from both the peroxisome and mitochondria, and the can be altered by
peroxisomal and mitochondrial dysfunction,24,144,156 and FDPS is susceptible to inhibition by statins.155
Given the increased fish size and nutrient availability at GLEN compared to the upstream sites, as
well as the high levels of glucose and lipids in fish there,12 we would expect protein expression and lipid
content profiles inverse to those found in starved fish. This generally includes downregulation of proteins
involved in β-oxidation, oxidative stress response, and the TCA, as well as reduced cholesterol and lipid
content.145 In the Outflow group, oxidative stress proteins, and peroxisomal β-oxidation proteins are
observed, as expected, and increases in lipid content were observed at the GLEN site compared to others12.
However, downregulation is seen in several proteins involved in cholesterol synthesis and bile export, which
is necessary for dietary fat absorption.154 Changes in lipid metabolism have been commonly observed after
MWWE exposure. Increased peroxisomal proliferation, fatty acid metabolism, and changes in PPAR or
associated genes is particularly associated with fibrate exposure.10,21 Metabolomic and proteomic analysis
of goldfish in WWTP outflow in Cootes Paradise Marsh, Ontario, Canada, found increased plasma carnitine
metabolites and decreased bile acid synthesis in MWWE exposed fish, along with changes in pathways
associated with lipid accumulation that varied with degree and length of exposure.16
Additionally, the downregulation of CS and MPC2, which control entry of acetyl-CoA and pyruvate
into the TCA, and decreases in ACADVL suggest a downregulation of mitochondrial β-oxidation and the
TCA. The TCA is both the main source of ATP for eukaryotes and produces a large number metabolites
for many biosynthetic and metabolic processes, including continued peroxisomal β-oxidation,24,144 so we
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would expect upregulation of TCA proteins compared to less well fed fish.145 Thus, the changes in the
Outflow group are difficult to explain solely as the result of increased nutrient availability.
Peroxisome and mitochondria function and regulation are closely related, and dysfunction in one or-
ganelle is known to affect the other. Increased peroxisomal β-oxidation due to statins or other PPAR
inducers could lead to alterations to ROS, lipid, or other metabolite concentrations that impact mito-
chondrial function or lead to compensatory regulation of mitochondrial function.24 Taken together, the
differential expression of lipid metabolic proteins at the GLEN site suggest that there are complex in-
teracting factors acting on lipid and other metabolic functions. While some changes are consistent with
increased nutrient availability, it is unlikely to be the sole factor.
Splicing and Cell Cycle Regulation
Multiple key proteins in the spliceosome complex were downregulated in the Outflow group (Figure 3.12).
Members of the U2, U4, and U5 small nuclear ribonucleoproteins (snRNPs) were all downregulated.The
snRNPs are core components of the spliceosome, and as such are regulators of gene translation.157. Core
member of the Prp19 complex, CDC5L and CTNNBL1, were also downregulated (Table 3.2) The Prp19
complex is a core spliceosome member, and evidence from studies in yeast suggest that it also has roles in
genome maintenance, protein modification and degradation, and gene transcription.158
A number of proteins involved in regulation of apoptosis were differentially expressed in the Outflow
group compared to the upstream group. Apoptosis inhibitor 5 (API5), a highly conserved protein which
inhibits apoptosis in response to DNA damage signaling,159 was downregulated approximately 1.5-fold,
while the pro-apoptotic protein AIFM2 (apoptosis inducing factor, mitochondrion-associated 2) was in-
creased two-fold (Table 3.2). Two anti-apoptotic annexin proteins, ANXA4 and ANXA11b, with roles in
cell structure and cytokinesis160,161 were downregulated at the GLEN site. Additionally, histone protein
ANO9A, a homolog of Histone H2B116, was downregulated at the GLEN site. Histone H2B has been found
to be bound to double stranded breaks to help induce DNA repair162, suggesting a reduced capability for
DNA repair. Upregulation of apoptosis is commonly found after exposure to contaminants and is often
considered as a biomarker of exposure.27
The study of MWWE exposure in Cootes Paradise Marsh referenced in Section 3.3.6 also found in-
hibition of pathways related to organism growth and entry into S-phase in exposed fish. Changes in
cell death related pathways were also observed, with the mostly heavily-exposed caged fish showing in-
crease in apoptotic pathways in the liver, while the wild fish showed upregulation of pathways involved
in inhibition of apoptosis. This suggests adaptation to MWWE effects over time, as the wild fish were
exposed to MWWE for much longer than the caged fish.16 Exposure to WWTP effluent was also shown
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Figure 3.12: Downregulated splicesome proteins in the Outflow group.
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to increase DNA damage in a dose-dependent manner, regardless of whether it underwent primary or
secondary treatment.163
Impacts of Temperature
A key difference between the GLEN site and other caging sites is the 6 ◦C difference in water temperature
due to the waste water treatment plant effluent (Table B.2). Oxidative stress is a known effect of tempera-
ture shock in teleosts, but is generally found in a response to a cold temperature shock rather than elevated
temperatures.164 Wen et al. [165] found increased expression of UCP1 and oxidative stress protein such as
glutathione S-tranferase (GST) omega-1 (GST), and decreased expression of FLNB, a signaling protein,
with a 14 ◦C decrease in temperature, while similar changes are observed in the Outflow group with a 6 ◦C
increase. FHM are robust organisms, capable of surviving a wide range of environmental conditions and
temperatures, and the water temperatures at all sites are within ranges normal for the FHM.166 Thus, any
temperature specific effects on protein expression are likely minimal.
One notable temperature related protein is UCP1, upregulated 2.2-fold in the Outflow group, and 1.8-
fold in the Downstream group, though the downstream p-value is over the significance threshold after FDR
adjustment (Table 3.2). UCP1 is mainly expressed in liver, but the response to thermal shock varies, with
expression increasing, decreasing, and remaining unchanged with temperature change depending on tissue
and species,165,167 UCPs are ’uncoupling’ proteins, allowing proton leakage through the mitochondrial inner
membrane, producing heat, reducing ROS formation, and disconnecting ATP production from oxidative
phosphorylation.167 Rather than responding only to temperature changes, UCPs may also be connected to
ROS response through PPARs, reducing mitochondrial ROS formation and alleviating oxidative stress.164
Thus, the upregulation of UCP1 may be a connected to increased ROS, rather than temperature differences.
Increased expression of UCP may be connected to the downregulation of mitochondrial proteins previously
discussed in Section 3.3.6.
3.4 Reduced Differential Expression in the Downstream Group
Only 23 proteins are differentially expressed between the Downstream Group and the Upstream group
(Table 3.2). Most of the differentially expressed proteins are also differentially expressed in the Outflow
group, and the direction of change of proteins differentially expressed in both groups is consistent, and only
varies by magnitude, with the Downstream groups showing reduced effect size. Only four enriched KEGG
pathways were found (Figure 3.9), and three of them are also enriched in the Outflow group compared to
upstream.
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3.5 Gene Set Enrichment Analysis
GSEA was performed on the 895 proteins used for differential expression analysis using combined gene sets
from GO Biological Process, Molecular Function, and Reactome Pathways. 105 gene sets were enriched
between the Outflow and Upstream groups, and 112 were enriched between the Downstream and Upstream
groups with a FDR of 20%.
GSEA identified overlapping clusters of gene sets that align with many of the enriched pathways
identified in the enriched genes. Figure 3.13 shows cluster of positively enriched gene sets for xenobiotic
transformation, peroxisomal β-oxidation, and various amino acid and other metabolic functions in the
Outflow group compared to Upstream, while mRNA splicing and RNA binding clusters were negatively
enriched.
Additional gene sets can also be identified in the GSEA data. A cluster of overlapping gene sets for
cytoskeleton arrangement and actin binding was also enriched in the Upstream group compared to both
the Outflow and Downstream groups, as was a cluster contains gene sets corresponding to ‘M Phase’ and
‘Signaling by Rho GTPases.’ Changes in actin binding and cytoskeleton organization are consistent with
the downregulation of MAPRE3B and KRT8 in both the Outflow and Downstream group compared to
upstream. Rho GTPases are important regulators of actin, and mitotic phase involves massive reorgani-
zation of the cell.168 This suggests that cellular growth and organization is impacted downstream of the
WWTPs.
GSEA also revealed that similar gene set enrichment occurred in the Downstream group compared to
the Upstream, despite few differentially expressed genes after FDR adjustment. As can be seen in Figure
3.13, the vast majority of gene set positively or negatively enriched in the Upstream group show the same
expression pattern in the Downstream group. This suggests that the changes observed in the GLEN site
are continuing downstream at a reduced level, which is consistent with the observed concentrations of
various contaminants at the sites (Table B.1).
Finally, 4 gene set clusters show opposing expression patterns between the Outflow and Downstream
groups compared to Upstream. The clusters labeled ‘CDH1 Replication Control’, ‘Protein Glycosylation’,
‘Translation Regulation’, and ‘Protein Modification’ are all downregulated in the Outflow group, but
upregulated in the Downstream. Cadherin-1, or E-cadherin is important in regulating cell division and
degrading proteins during the end of mitosis, and plays a role as a tumor suppressor. Signaling pathways
related to E-cadherin involve ubiquitination, phosphorylation and other protein modifications, as well a
transcriptional regulation169, and gene set clusters with these functions are differentially enriched between
the Outflow and Downstream groups as well. It is possible that the increased oxidative stress and xenobiotic
exposure at the GLEN site is impacting cell division through oxidative damage to DNA or other effects.
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Figure 3.13: Comparison of enriched gene sets at an FDR of 20%. Gene sets from GO biological process
and molecular function, as well as Reactome pathways were scored for enrichment using GSEA against the
895 proteins with expression data, and sets were then combined using automatic annotation analysis. The
left side of each node indicates the enrichment of that set in the Outflow group vs the Upstream group,
and the right side indicates the Downstream group vs Upstream.
73
3.6 Conclusions
This study has identified 3698 protein sequences from the FHM liver proteome by mass spectrometry.
From the 895 proteins within the thresholds for quantification, 164 were significantly differentially ex-
pressed between the three Upstream, Outflow, and Downstream groups. GSEA and functional analysis
of differentially expressed proteins shows that proteins involved in xenobiotic transformation, oxidative
stress, and lipid metabolism were increased in sites downstream of the WWTPs, while proteins involved
in mRNA splicing and cytoskeleton arrangement were decreased. Despite multiple confounding factors
between sites, including variations in temperature and nutrient availability, the response was generally
consistent with the concentrations of various PPCPs at the sites.
While many of the observed changes are consistent with both effluent concentration and other studies
of MWWE and contaminant exposure, care should be taken when interpreting the results. While the
comparison is between sites upstream and downstream of the WWTPs, a variety of factors other than
MWWE exposure could impact the hepatic proteome. This includes the contaminants from other sources
such as urban and rural runoff and stormwater outfalls, and changes in nutrient availability and water
quality downstream of the WWTPs. Since proteome changes can be sex-specific, the different ratio of
male to female fish across sites may impact the observed changes. Additionally, while the grouping of the
caging sites for differential expression analysis improves the statistical power by reducing the number of
comparisons, it also means that sites with differing conditions are combined into one group. In particular,
CUSH receives urban and rural runoff from Calgary and surrounding communities that is not present
in the other upstream site, BEAR. Lazaro-Côté et al. [12] found that whole-body glycogen content and
condition factor was significantly higher for fish caged at CUSH compared to BEAR, while the water
quality parameters and select PPCP concentrations are similar between theses sites (Tables B.2 and B.1,
also Lazaro-Côté et al. [12]). This suggests that other, non-effluent contaminant sources may be impacted
the caged fish, and proteome changes should not be directly ascribed to MWWE exposure.
While the large changes in CYP and oxidative stress protein abundance would suggest them as potential
biomarkers, the wide variety of CYP proteins, and the variability of oxidative stress proteins limit their
usefulness. Instead, examining lipid peroxidation or mitochondrial capacity of exposed fish may provide a
more accurate biomarker of the impacts of exposure.27,142 The effect on proteins involve in mRNA splicing
suggest that investigation of the effects of MWWE exposure on transcript regulation may yield further
insight.
Finally, gene sets involved in CDH1 cell cycle control, protein modification, and translation initiation
were differentially enriched between fish at the Glen site and sites further downstream. Further study
of post-translational modifications in the proteome would be beneficial to understand how regulatory
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pathways are being altered.
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Chapter 4
Conclusions and Future Directions
This thesis describes the use of proteomics to investigate changes in the fathead minnow (FHM) hepatic
proteome downstream of wastewater treatment plants (WWTPs) in the Bow River in Calgary, Alberta.
Different methods and tools for the identification of protein sequences from mass spectrometry (MS) data
in a non-model organism were compared to determine the best method for accurate proteomics analysis.
The method was then applied to fish liver samples generated from a caging experiment in the Bow River
in the Calgary area. Changes in the liver proteome revealed increased xenobiotic metabolism, oxidative
stress, and peroxisomal lipid metabolism, as well as changes in mitochondrial activity, mRNA splicing,
and cadherin related cell cycle control in fish downstream of the WWTPs.
Chapter 2 investigates the selection of a protein database for the identification of proteins from
FHM liver MS samples. Comparison between a protein collection (the UniRef90 Cyprinidae Proteome
(U90CYP)), a reference proteome from another organism (the Uniprot Zebrafish Reference Proteome
(ZRP)), and a genome derived database (the Fathead Minnow Predicted Proteome (FHMP)) revealed
that more proteins could be identified when using a genome-derived database. This suggests two key
points for the use of proteomics, particularly when studying non-model organisms:
1. The protein database requires careful selection. While proteins can be identified using a cross-species
database, few identical peptides were found in both the FHM genome and the U90CYP. This will
reduce the number proteins that can be identified, potentially preventing identification of biologically
relevant proteins. It will also bias identified proteins toward more conserved proteins, potentially
missing species-specific adaptations.
2. The integrations of omics data is beneficial for ecotoxicology. By building off previous genome
sequencing work59,60, several hundred additional proteins were identified, improving the ability to
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identify relevant changes in the proteome. While genome sequence data is not available for many
non-model organism, tools like ProteomeGenerator67 make the integration of transcriptomic and
proteomic data increasingly accessible.
An interesting possibility for the second point is the ability to iteratively improve genome annotations
using mass spectrometry data. Proteomics has previously been used to improve and refine gene and exon
models in genome sequence data (for example, [81]). By mapping identified peptides back to the genome,
gene prediction models and exon boundaries can be improved. This could also use peptides from de novo
sequencing tools such as PEAKS50 to identify missing or novel genes. The improved gene database could
then be used for future proteomics experiment with more accurate results. Transcriptomics data could
also be included to further improve the database.
Chapter 3 compares protein expression in the fathead minnow liver across several sites in the Bow River.
Expression changes were highest in the GLEN site, which is expected given the elevated temperatures and
high concentration of effluent compared to other sites. Proteins involved in xenobiotic metabolism, oxida-
tive stress response, and peroxisomal lipid metabolism were upregulated. Many of the proteins, such as
glutathione S-transferases, have been previously studied as markers of xenobiotic exposures. The increase
in peroxisomal lipid metabolism proteins strongly suggests exposure to a peroxisome proliferator-activated
receptor (PPAR) inducer, such as fibrates or statins.10 The downregulation of mitochondrial β-oxidation,
and tricarboxylic acid cycle (TCA) proteins is an interesting find in the presence of increased peroxisomal
lipid metabolism. The TCA is a key metabolic pathway, and downregulation in the nutrient-enriched
WWTP outflow is unexpected. Additionally, the protein UCP1 was highly upregulated, which suggests
‘decoupling’ of mitochondrial oxidative phosphorylation from ATP generation and changes in mitochon-
drial redox status.164 ROS management and lipid metabolism are key roles of peroxisomes32, and there is
significant regulatory interplay between peroxisomes and mitochondria.24 Exposure to PPAR activators
could be increasing lipid metabolism, which along with the effects of increased xenobiotic metabolism,
lead sustained oxidative stress. The upregulation of UCP1 may be the effect of PPAR activation or in-
creased ROS burden. The alteration to mitochondrial proteins in fish at the GLEN site suggests testing
mitochondrial activity as a potentially useful biomarker, especially when PPAR activators such as statins
or fibrates are expected in WWTP effluent.
While few proteins were differentially expressed in the sites further downstream, proteins that were
differentially expressed showed a similar expression profile to the GLEN site. Additionally, Gene Set En-
richment Analysis (GSEA) showed a generally consistent response between the GLEN and the downstream
sites. However, gene sets for cadherin-related cell cycle control, protein modification and translation initi-
ation were downregulated in the GLEN site, but upregulated further downstream. A possible explanation
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of this difference is that the increased reactive oxygen species (ROS) production in fish in the GLEN
site induced sufficient oxidative damage to DNA, RNA, and cellular membranes32 to impact cell cycle
and growth. Further investigation of RNA splicing and protein modification after municipal wastewater
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A.1 Code Used for Analysis











from pyfaidx import Fasta
from Bio import SeqIO
from Bio.Seq import Seq
from Bio.SeqRecord import SeqRecord
from Bio.Data.CodonTable import TranslationError
def getargs(argv=None):
parser = argparse.ArgumentParser(description="Read a gff3 file into a sqlite database using gffutils and produce "\
"fasta formatted protein or transcript sequences from the "\
"corresponding genome")
parser.add_argument("−−out_dir", metavar="output directory",
help="Output directory. Will be created if it doesn't already exist.")
parser.add_argument("−−out_name", metavar="output filename",
help="Name of the output fasta file.")
parser.add_argument("−−gff3",
help="gff3 file containing features to be translated to fasta format. If a db file with the "\
"same name is found in the output directory, that db will be used instead.")
parser.add_argument("−−ref",
help="Reference genome in fasta format")
parser.add_argument("−−in_mem", required=False, action="store_true",
help="Keep the feature database in memory. By default, it will be created on disk in the "\
"output directory.")
parser.add_argument("−−transcripts", action='store_true', required=False,
help="Output DNA transcript sequences instead of protein sequences.")
parser.add_argument("−−incomplete", action='store_true', required=False,






gff3_base, ext = os.path.splitext(os.path.basename(args.gff3))
db_path = os.path.join(out_dir, gff3_base + ".db")
try:
os.makedirs(out_dir, exist_ok=True)
except OSError as err:
print(err.strerror)
print("Could not open output directory.")
sys.exit(1)
if os.path.isfile(db_path) and not args.in_mem:
print("Existing database matching ", gff3_base, " found in output directory. Skipping database creation.")
db=gffutils.FeatureDB(db_path)
else:





out_file = os.path.join(out_dir, args.out_name)
print("Looking for ", out_type, "s in ", db_path, sep="")
with open(out_file, "w") as out_handle:
SeqIO.write(protein_recs(db, genome, not args.incomplete, out_type=out_type), out_handle, "fasta")
def make_db(input_gff, db_output_path, in_mem=False):
if in_mem:
print("Using in−memory database")
db = gffutils.create_db(input_gff, ":memory:", verbose=True, keep_order=True)
else:
gffutils.create_db(input_gff, db_output_path, verbose=True, keep_order=True)
db = gffutils.FeatureDB(db_output_path)
return db
def protein_recs(db, genome, full_cds, out_type):
"""
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def translate_feature(db, genome_obj, parent_feature, child_name, out_type="protein", full_cds=True):
"""
A generator returning BioPython Seq objects created from gffutils features.
Given a parent feature name, a pyfaidx genome object, and the child feature
name, iterate over all child features in the parent feature, combine their
sequences, and create a seq object with a description from the gff
annotations. The child feature can describe a complete CDS with start and
stop codons, or a just a sequence in one complete reading frame.
Keyword Arguments:
db: the database to search
parent_feature: name of the parent feature type to create the sequence for
genome_obj: a Fasta genome object created by pyfaidx that contains sequence
information
child_name: the feature name of the child features
full_cds: if True, the translation will only yield a sequence if in−frame
stop and start codons are in the place, otherwise it just checks
if the reading frame is complete (i.e. len(seq) % 3 == 0)
"""
skipped = 0
for feature in db.features_of_type(parent_feature):
seq_exons = []
for exon in db.children(feature, featuretype=child_name, order_by="start"):
seq_exons.append(exon.sequence(genome_obj, use_strand=False))
gene_seq = Seq("".join(seq_exons))
# skip incorrect length CDS
if feature.strand == "−":
gene_seq = gene_seq.reverse_complement()
if out_type == "protein":
with warnings.catch_warnings():
# We want to catch incomplete (not 3 frame) coding sequences)
# if cds=True, this is raised as an error, and will also check if
# the sequence begins and ends with correct start/stop codons
# if cds=False, start/stop won't be checked, and partial sequences
# will only raise a warning, so we need to upgrade it to an error
# to properly skip it
warnings.simplefilter("error")
try:
protein_seq = gene_seq.translate(cds=full_cds, to_stop=True)
# if "*" in protein_seq: # if there's a stop codon in the sequence# raise TranslationError
seq_description = make_seq_header(feature)
# translated += 1
yield SeqRecord(protein_seq, id=feature.id, description=seq_description)
except (TranslationError, Warning):
skipped += 1
elif out_type == "transcript":
seq_description = make_seq_header(feature)
yield SeqRecord(gene_seq, id=feature.id, description=seq_description)
else:
print(out_type, " is not a valid output type.")
if skipped > 0:
print("Skipped ", skipped, " features")
def make_seq_header(annotated_feature, key_list=None):
"""
Given some annotated feature from a gffutils database, and a list of keys
for the annotation, return an underscore separated string with the key values.
Keyword Arguments:
annotated_feature: an annotated feature from the gffutils db
key_list: a list of keys to append, by default "Besthit", "Symbol", "Description", "Acc"
Returns:
underscore separated string of key values
"""
if key_list is None:
key_list = ["Besthit", "Symbol", "Description", "Acc"]
seq_description = []








if __name__ == '__main__':
arguments = getargs()
main(arguments)
Listing A.2: BASH script for creating complete protein database from genome sequence and annotions.
#! /bin/bash
################################################################################
# Mark Lubberts − 3 March 2019
# Script to create the fasta formatted protein database for LC−MS proteomics
# analysis of fathead minnow, using the SETAC fathead minnow genome and
# corresponding annotations as the input, along with a Uniprot protein database



















REDUNDANCY_LVLS=( 1.00 0.95 0.90 0.85 )
# Create initial protein and transcript files













echo " −−−−Creating Blast database−−−− "
makeblastdb −dbtype prot \
−title "$REF_PROT_DB DB" \
−out "${TRD_OUT}/ref_prot_db" \
−in "$REF_PROT_DB"
echo " −−−−Running TransDecoder−−−− "





echo " −−−−Running BLAST Search−−−− "







echo " −−−−Running HMMScan Search−−−− "
tempfile=$(mktemp)






# Run Transdecoder using homology information
echo " −−−−TransDecoder Prediction−−−− "
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echo " −−−−Concatenating Proteins Files−−−− "
cat "$AUGUSTUS_OUT" "${ZF_CDS_OUT}.transdecoder.pep" > "$OUT_DB"
echo " −−−−Filtering Protein Fasta−−−− "
tempfile=$(mktemp)
cp "$OUT_DB" "$tempfile"
"$FILTER_SCRIPT" "$tempfile" "$FILTER_LIST" > "$OUT_DB"
echo " −−−−Creating Non−redundant Files−−−− "
IN_DB="${OUT_DB##*/}"for LEVEL in ${REDUNDANCY_LVLS[@]}; do
DB_NAME="${LEVEL}_${IN_DB}"
cdhit −c ${LEVEL} −M 102400 −g 1 −d 1000 −i "$OUT_DB" −o "$DB_NAME"
done
cd ${CWD}




# Mark Lubberts − 3 March 2019
# Program perform in−silico digestion of protein or all proteins in a fasta file
# then plots distribution of peptides. If more than one fasta file is given,





from Bio import SeqIO
from tryptic_digest_funcs import get_peptide_list, get_length_freq, digest_protein, get_unique_peptides
from pandas import DataFrame, Series
import matplotlib
# prevent complaints about display when headless
matplotlib.use("Agg")
from matplotlib import pyplot as plt
import numpy as np
from matplotlib_venn import venn2_unweighted, venn3_unweighted
from textwrap import wrap
if __name__ == "__main__":
parser = argparse.ArgumentParser(description="Check for and score unique peptides in a protein sequence")
parser.add_argument("sequence", type=str, nargs='+',
help="The protein sequence or fasta file")
parser.add_argument("−−misses", type=int, default=1,
help="The number of missed cleavages. (default: %(default)s")
parser.add_argument("−−min", type=int, dest="min_length", default=7,
help="The minimum peptide length to check. (default: %(default)s)")
parser.add_argument("−−max", type=int, dest="max_length", default=30,
help="the maximum peptide length to check. (default: %(default)s)")
parser.add_argument("−−keep_iso", action="store_true", default=False,
help="Don't convert isoleucine to leucine. (default: convert)")
parser.add_argument("−−low_mem", action="store_true", default=False,
help="Use low memory mode, slower, but will decrease memory usage by ~50%%. Will always use 3 "
"cores. (default: off)")
parser.add_argument("−−n_core", type=int, default=4,
help="The number of cores to use when processing fasta files. More than 4 cores has minimal "
"effect on speed. (default: %(default)s, minimum: 1)")
parser.add_argument("−−fasta", action="store_true",
help="Read protein sequence from a fasta file. (default: from string)")
parser.add_argument("−−ambiguous", action="store_true",
help="Retain peptides with ambiguous ('X') amino acids (default: discard)")
parser.add_argument("−−out_dir", type=str, default=".",
help="Output directory for graphs. Applicable for fasta file input. (default: current "
"directory)")
parser.add_argument("−−cutoff", type=int, dest="cutoff_length", nargs="?", const=7,
help="Draw a vertical line on output graphs at the peptide length specified. The default length"
" is 7 if no integer argument is given, or no line if the flag is not used.")
args = parser.parse_args()
if args.fasta:














length_qty_columns = list(range(args.min_length, args.max_length + 1))









possible_peptides_fig, possible_peptides_ax = plt.subplots()
uniq_fraction_fig, unique_fraction_ax = plt.subplots()
for file in args.sequence:
db_size = len([1 for line in open(file) if line.startswith(">")])










unique_peptides, unique_length_freq = get_unique_peptides(peptides)
peptides = set(peptides)
pep_length_freq = get_length_freq(peptides)
db_name, ext = os.path.splitext(os.path.basename(file))






results[db_name+"_potential"] = Series({"db_size": db_size}).append(pep_length_freq)







# Do we need to log scale data?
use_log_scale = False
if max(bar_peptide_value) > 20*min(bar_peptide_value):use_log_scale = True
print("log scaling graph")
# set up the x−axis limits
x_limits = [args.min_length, args.max_length + 1]
# plt.figure("num_peptides")














if args.cutoff_length is not None:
unique_fraction_ax.axvline(args.cutoff_length, color='r', linestyle=':')
unique_fraction_ax.set_title("Fraction of unique tryptic peptides versus peptide length")
unique_fraction_ax.legend()
unique_fraction_ax.set_ylabel("Fraction of Unique peptides")
unique_fraction_ax.set_xlabel("Peptide length (residues)")








bar1 = ax.bar(bar_plot_index, bar_peptide_value, bar_width, label="Possible")
bar2 = ax.bar(bar_plot_index+bar_width, bar_unique_value, bar_width, label="Unique")
ax.set_xlabel("Database")
ax.set_ylabel("Number of Peptides")








out_file = os.path.join(out_dir, "total_peptides.png")
plt.savefig(out_file)
plt.close()
# if len(peptides_dict) < 4:
# if len(peptides_dict) == 2:
# venn2_unweighted([peptides_dict[db] for db in peptides_dict.keys()],
# set_labels=[db for db in peptides_dict.keys()])
# elif len(peptides_dict) == 3:
# venn3_unweighted([peptides_dict[db] for db in peptides_dict.keys()],
# set_labels=[db for db in peptides_dict.keys()])




# print("skipping drawing venn, too many items")
results.to_csv("tryptic_digest_results.csv", index_label="db_name")
else:
# sequence = args.sequence[0]
for seq in args.sequence:
peptides = list(digest_protein(seq, args.misses, args.min_length, args.max_length, args.keep_iso))
pep_length_freq = get_length_freq(peptides)
print(pep_length_freq)
Listing A.4: Python code for performing in-silico tryptic digests.
#! /usr/bin/env python3
################################################################################
# Mark Lubberts − 3 March 2019
# functions for in−silico tryptic digest of a protein or protein fasta files
################################################################################
from pandas import value_counts, unique
import multiprocessing as mp
from functools import partial
def digest_protein(protein_sequence, misses=1, l_min=7, l_max=30,
convert_isoleucine=True, as_list=False, ambiguous_peptides=False):
"""Perform in−silico digestion of a protein sequence with a specified enzyme
Loop through a string specifying a protein sequence and return a set of strings of peptides that would be produced
by digesting the protein with trypsin with up to the specified number of misses cleavages
Params:
prot_sequence: string: amino acid sequence of the protein
misses: integer: with the number of allowed missed cleavages by the enzyme
min_length: integer: of the minimum peptide length to include in the list, default value is 7
max_length: integer: of the maximum peptide length to include in the list, default is 30
convert_isoleucine: bool: Convert isoleucine to leucine before digesting
as_list: bool: Output the peptides as a list instead of a set. This will keep redundant peptides in the output.
ambiguous_peptides: Keep peptides with ambiguous ('X', by IUPAC standards) amino acids
Returns:
peptides: set or list of strings of peptides produced, with complete sequence if no cut sites are found
"""
peptides = []
enzyme_sites = {"K", "R"}
# split_sites is a list of positions the protein sequences will be split at. If there are no cut sites, the list
# should be [0,len(seq()], since python is zero−indexed and specifies intervals half open (e.g. a list length five
# has indexes 0,1,2,3,4)
split_sites = [0]
if convert_isoleucine:
protein_sequence = protein_sequence.replace("I", "L")
# find all the enzyme cut sites in the protein sequence. If the last peptide is K/R, the 'cut site' is skipped,
# because it's outside of the protein length
for i in range(len(protein_sequence)):
if protein_sequence[i] is "*":split_sites.extend([i−1, i])




# loop to create position pairs from split_sites that define new peptides and grab them from the protein sequence
for i in range(misses+1):
# Loop through number of missed cleavages. For 1 missed cleavages, the protein would be cut at index 0 and 0+1,
# and 0 and 0+2
i += 1
if i < len(split_sites): # Can't have more missed cut sites than cut sites
for j in range(len(split_sites)−i):
# j and j+i are the index in split_sites of the positions we want to cut, so split_sites[j] and
# split_sites[j+i] give the index position in protein_sequence of the new peptide
start = split_sites[j]
stop = split_sites[j+i]
if stop−start in range(l_min, l_max+1):
# ignore peptides outside of min/max length
new_peptide = protein_sequence[start:stop]
if ("X" not in new_peptide or ambiguous_peptides) and ("*" not in new_peptide):# If the peptide sequence contains an 'X' we don't want it, unless specifically asked.
peptides.append(protein_sequence[start:stop])
else: # if the we have more missed cut sites that cut sites, stop loop
break




"""Convert the BioPython Seq object to a string in a generator"""
for record in seq_obj_iter:
yield(str(record.seq))
def chunkify_list(the_list, k):
"""divide the_list into a list of k sublists. From MaPePeR on stackoverflow"""
from math import log10
n = len(the_list)
k = k*int(max((1, log10(n) − 2))) # Try splitting large lists into more chunks to struct size errorchunkified_list = [the_list[i*(n//k) + min(i, n % k):(i+1) * (n//k)+min(i+1, n % k)] for i in range(k)]
return chunkified_list
def list_worker(protein_list, as_list=False, **kwargs):"""Wrapper function for digest_protein to produce a peptide set from a protein list"""
if as_list is True:
peptide_set = list()




for prot in protein_list:
peptide_set.update(digest_protein(prot, as_list=as_list, **kwargs))peptide_set = list(peptide_set)
return peptide_set
def get_peptide_list(seqobject_iterator, n_core=4, low_mem=False, redundant=False, **kwargs):"""Perform in−silico digest of all protein SeqObject in an iterable, and returns a list of unique peptides
Given an iterable or generator of Biopython SeqObjects, will loop through all items in the iterable and find their
tryptic peptides, using one of three methods. If n_core == 1, will loop through and add peptides to the set one
protein at a time, checking for redundant peptides each time. If n_core > 1 AND low_mem == True, will convert
SeqObjects using a generator, and pass them to n_core−1 process for digest. Results from the worker processes will
be asynchronously and immediately added to the peptide set. This keeps memory usage ~equal to the final peptide list
size, but since one process is handling the generator and peptide set updating at the same time, does not scale well
with n_core. If n_core > 1 and low_mem !=True, the iterable will be converted to a string list, split n_core ways,
sent to n_core processes, then combined and deduplicated afterwards. Note that each worker process will still remove
redundant peptides, as this has significant effects on memory usage and not much on speed, as the very short, highly
repetitive proteins can be removed on a per core basis, rather than afterwards. This scales better with n_cores, but
increases memory usage on large protein sets.
Params:
seq_obj_iter = iterable of Biopython SeqObjects
n_core = number of processes to use
low_mem = work in (slightly) slower low memory mode
redundant: Bool: Keep redundant peptides
**kwargs = arguments to pass to digest_protein
Returns:
all_peptides = list of unique peptides
"""




if n_core == 1:
for prot in seq_generator(seqobject_iterator):
if redundant is True:
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all_peptides += digest_protein(prot, as_list=redundant, **kwargs)else:
all_peptides.update(digest_protein(prot, as_list=redundant, **kwargs))
elif low_mem is True:
# use a generator to convert seqObjects to strings, pass to digest_protein then combine resulting peptides sets
# The imap function is asynchronous, so the main process will start updating as soon as it
# gets results from the first protein. This means the memory used is ~equal to the final
# size of the peptides set, however, the generator and set update are performed on the same
# process, limiting multiprocessing to ~3 cores.
pool = mp.Pool(max(n_core−1, 1))
worker_partial = partial(digest_protein, as_list=redundant, **kwargs)for result in pool.imap_unordered(worker_partial, seq_generator(seqobject_iterator), 7):








# break the list in n_core equal lengths. This is *much* faster than passing the whole list# to pool.map() and letting it hand things out.
prot_list = chunkify_list([str(prot.seq) for prot in seqobject_iterator], n_core)
pool = mp.Pool(n_core)
# Create a partial from the digest_protein wrapper function to handle the list chunk
worker_partial = partial(list_worker, as_list=redundant, **kwargs)results = pool.map(worker_partial, prot_list)
# append to list and then remove redundant with pandas unique()
for result in results: # This is one list per individual 'chunk' of the protein list
for peptide_list in result:
all_peptides += peptide_list







"""function to convert a list of strings (ie. peptides) to a Series with frequency of each observed string length"""
str_length_frequency = value_counts([len(string) for string in string_list], sort=False, dropna=False).sort_index()
return str_length_frequency
def seq_parse_filter(seqobject_iterator, filter_string, keep=False):
"""Parse a fasta file and filter by sequence description/name"""
for seq in seqobject_iterator:
if filter_string in seq.description and keep:
yield(seq)
elif filter_string not in seq.description and not keep:
yield(seq)
def get_unique_peptides(redundant_peptide_list):
"""Find all peptide sequences with only one occurrence in the list.
:param redundant_peptide_list: a list of peptide strings with redundancy
:return: a list single occurrence strings and a Pandas series of frequency of string lengths.
"""
unique_peptides = value_counts(redundant_peptide_list)




if __name__ == "__main__":
print("this is just functions to use")
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A.2 Additional Figures






















Figure A.2: Distribution of conserved domain arrangements (CDAs) in the FHMP at various levels of
clustering.
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Figure A.3: Percent overlap between the target and decoy database versus db size in tryptic peptides. The
number of proteins in the database is indicated next to each point.
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Figure A.4: Comparison of PSM scores between the FHMP and U90CYP databases for PSMs which





Figure A.5: Overlap in peptide-spectrum matches (PSMs) and peptide and protein identifications between
search engines in the trout and human datasets. a) and b) PSM overlap in human and trout, respectively.




Table A.1: Decoy and Target PSM scoring values. Ion Count refers to the number of ions per mass spectra
matched to the theoretical spectra




Fathead Minnow Predicted Proteome
(FHMP)
Target 1.65 12.43 0.307
Decoy 1.14 10.07 0.517
UniRef90 Cyprinidae Proteome
(U90CYP)
Target 1.60 12.12 0.322
Decoy 1.17 10.17 0.490
A.4 Search Tool Comparison Parameters
Table A.2: Parameters for the Search Engine Comparison.
Tool Parameter SampleHuman Trout FHM
All Fixed Mods TMT, CarboVariable Mods Oxidation of Methionine
Comet
Peptide Mass Tolerance 10 ppm 0.1Da 15 ppm
Fragment Bin Tolerance 1.0005 0.02 1.0005
Fragment Bin Offset 0.4 0.0 0.4
MSFragger Precursor Mass Tolerance ±500Fragment Mass Tolerance 0.6Da 0.6Da 0.6Da
X!Tandem Parent Monoisotopic Mass Error 10 ppm 0.1Da 15 ppmFragment Monoisotopic Mass Error 0.6Da 0.2Da 0.1Da
PEAKS 8.5 Parent Mass Error Tolerance 10 ppm 0.1Da 10 ppmFragment Mass Error Tolerance 0.6Da 0.2Da 0.1Da
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B.1 Water Quality and Contaminants Data
Table B.1: Average concentrations of select contaminants in the three groups. MDL, minimum detection
limit. Concentrations in undiluted effluent from the Pine Creek WWTP are provided for comparison.
Compound MDL Upstream Outflow Downstream Pine Creek*
Neutral PPCPs
Cotinine 0.005 ND 0.034 0.005 0.034
Caffeine 0.010 0.010 0.127 0.022 0.022
Trimethoprim 0.004 ND 0.227 0.014 0.227
Carbamazepine 0.002 ND 0.393 0.026 0.482
Acidic PPCPs
Naproxen 0.004 ND 0.086 0.007 0.029
Diclofenac 0.004 ND 0.480 0.051 0.507
Ibuprofen 0.007 ND 0.060 ND ND
Gemfibrozil 0.007 ND 0.017 ND ND
Antidepressants
Fluoxetine n/a ND 0.002 ND 0.005
Norfluoxetine n/a ND 0.014 ND 0.013
Venlafaxine n/a ND 0.472 0.023 0.538
O-Desmethylvenlafaxine n/a ND 1.514 0.082 1.735
Table B.2: Water quality data at the five sites. Superscripts indicate statistically significant groups after









BEAR 12.0± 0.3a 9.63± 0.51b 298.3± 1.5a 8.25± 0.03b 4.28± 1.37
CUSH 12.0± 0.5a 10.45± 0.14b 325.8± 2.1b 8.18± 0.08b 3.27± 0.36
GLEN 18.4± 0.2b 6.06± 0.25a 928.5± 3.6e 7.23± 0.08a 4.32± 0.53
H22X 12.5± 0.4a 11.04± 0.56b 376.0± 2.8c 8.19± 0.09b 5.06± 0.60
UPHI 12.3± 0.3a 9.91± 0.53b 397.4± 2.3d 8.00± 0.08b 4.33± 1.14
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Table B.3: Length(mm), weight(g), and condition factor of fathead minnows used for proteome analysis
after caging at the listed sites in the Bow River. Values are listed as mean ± SD. Letters within columns
indicate statistically significant differences between sites after Bonferroni correction for multiple tests.
Site Sex Ratio (M/F) Length (mm) Weight (g) Condition Factor
BEAR 2/4 48± 8 1.22± 0.71 1.049± 0.035a
CUSH 3/3 48± 8 1.55± 0.61 1.247± 0.200b
GLEN 3/3 51± 6 1.70± 0.64 1.198± 0.083b
H22X 3/3 46± 6 1.10± 0.47 1.104± 0.085ab
UPHI 1/5 45± 9 0.99± 0.54 1.079± 0.189ab
Table B.4: Characteristics and morphometrics of individal fathead minnows used for the proteomics study.
Fish ID is the same as used in Lazaro-Côté et al. [12], run indicates which of the three mass spectrometry













49 A 126 BEAR 1 M 1.03 10.8 46 1.058
51 B 130C BEAR 1 F 0.98 8.7 45 1.075
52 C 129C BEAR 1 M 0.96 8.1 46 0.986
42 A 131 BEAR 2 F 0.82 7.5 43 1.031
41 B 127C BEAR 2 M 2.65 7.9 63 1.060
48 C 127C BEAR 2 M 0.86 9.2 43 1.082
33 A 130N CUSH 1 M 2.06 7.2 55 1.238
37 B 129N CUSH 1 M 1.87 8.7 51 1.410
38 C 128C CUSH 1 F 0.43 8.0 34 1.094
26 A 127C CUSH 2 F 1.39 12.5 44 1.632
28 B 128N CUSH 2 F 1.55 7.9 47 1.493
32 C 126 CUSH 2 M 2.02 10.4 55 1.214
59 A 129C GLEN 1 F 1.25 7.8 48 1.130
61 B 131 GLEN 1 F 1.59 11.8 50 1.272
62 C 128N GLEN 1 M 2.18 12.4 55 1.310
71 A 130C GLEN 2 M 2.60 13.5 60 1.204
70 B 126 GLEN 2 M 1.75 9.0 53 1.175
68 C 130C GLEN 2 F 0.81 7.9 42 1.093
20 A 128C H22X 1 F 0.67 12.9 38 1.221
21 B 129C H22X 1 M 0.96 7.0 45 1.053
23 C 131 H22X 1 F 1.93 11.1 56 1.099
14 A 129N H22X 2 M 0.67 11.6 41 0.972
16 B 127N H22X 2 F 1.25 7.9 48 1.130
19 C 130N H22X 2 M 1.12 7.5 46 1.151
2 A 127N UPHI 1 M 0.73 12.1 42 0.985
4 B 128C UPHI 1 M 2.06 10.3 61 0.908
5 C 129N UPHI 1 M 0.65 10.7 36 1.393
10 A 128N UPHI 2 F 0.98 13.4 45 1.075
9 B 130N UPHI 2 M 0.63 8.8 41 0.914
8 C 127N UPHI 2 M 0.89 11.6 42 1.201
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B.2 Code Used for Analysis


























#### Load Raw Data ####
# file containing mapping of sample to label in each run
design_table <− fread("input_data/experiment_layout.txt")
# peptide file exported from TPP with the experiment label added and matching runs in the design_table file
pep_file <− "/mnt/storage/tpp_data/fhm/final_thesis_db/final_thesis_run/all.interact.ipro.pep.xls"
# protein IDs from the combined runs
prot_file <− "/mnt/storage/tpp_data/fhm/final_thesis_db/final_thesis_run/interact.ipro.prot.tsv"














# read the remapped peptides and filter out low quality peptides
quant_data_raw <− data.table(cleaned_data[[1]])
# PSMs from the same scan are duplicates detected by comet/X!Tandem
quant_data_raw <− unique(quant_data_raw, by=c("experiment_label", "start_scan", "peptide"))
prot_full_data <− data.table(cleaned_data[[2]])
quant_data_raw <− quant_data_raw[iprobability > 0.9,]
# Make MDS and bar plot of spectra intensities across all runs before normalization
peptide_intensity <− renamed_intensity_from_raw(quant_data_raw, design_table, keep_unlabelled = TRUE)
raw_mds_plots <− make_mds_plots(peptide_intensity)
output_plot(raw_mds_plots[[1]], img_dir, "raw_spectra_mds.png")
spectra_intensity <− renamed_intensity_from_raw(quant_data_raw, design_table, keep_unlabelled = FALSE, sum_peptide =
FALSE)
spectrum_boxplot <− plot_logfc_boxplot(spectra_intensity)
output_plot(spectrum_boxplot, img_dir,"raw_spectra_boxplot.png", width=12, height = 8)
#### run normalization and collate protein quantities ####




















# merge dataset by protein
quant_data <− merge(quant_a, quant_b, by=1, all.x = TRUE, all.y = TRUE)
quant_data <− merge(quant_data, quant_c, by=1, all.x = TRUE, all.y = TRUE)
# Remove NAs and unnecessary columns
quant_data <− quant_data[, !(names(quant_data) %in% colnameslike(quant_data, "n."))]
quant_data <− na.omit(quant_data)
# Make some plots
quant_data_melt <− melt(data.table(quant_data), id="protein", variable.name = "sample_id", value.name = "log2FC")
quant_data_melt[, c("site", "run", "cage", "sex") := tstrsplit(sample_id, split="\\.")]
run_labels <− c("Run A", "Run B", "Run C")
names(run_labels) <− c("A", "B", "C")
norm_fc_plot <− ggplot(quant_data_melt, aes(x=sample_id, y=log2FC, fill=site, linetype=sex)) +
geom_boxplot(notch=TRUE) +
theme_classic() +
facet_grid(.~run, scales = "free_x", labeller = labeller(run = run_labels)) +
theme(text = element_text(size=20), axis.text.x = element_text(angle = 90, vjust=0.5, hjust=0)) +
scale_fill_brewer(type = "qual", palette = "Set1") +
labs(fill="Caging Site", x="Sample", y="Normalized Log2 Fold−Change")





plot_file <− file.path(img_dir, "heatmap.png")
png(type = "cairo", filename = plot_file, width=10, height=10, units = "in", res = 300)
coolmap(as.matrix(as.data.table(quant_data), rownames = "protein"),






coolmap(as.matrix(as.data.table(quant_data), rownames = "protein"),





protein_boxplot <− plot_logfc_boxplot(quant_data, sort_columns = TRUE)
output_plot(protein_boxplot, img_dir,"normalized_protein_boxplot.png", height=8, width=12)
#### Set up limma experiment design ####
#quant_data <− quant_data[,c(1:28,30:31)]
# sample group of each column
# tr <− as.factor(rep(c("BEAR","BEAR","CUSH","CUSH","GLEN","GLEN","H22X","H22X","UPHI","UPHI"), 3))
tr <− as.factor(c(rep(c("BEAR","BEAR","CUSH","CUSH","GLEN","GLEN","H22X","H22X","UPHI","UPHI"), 2),
"BEAR","BEAR","CUSH","CUSH","GLEN","GLEN","H22X","UPHI","UPHI"))




exp <− as.factor(c(rep(1,10), rep(2,10), rep(3,9)))
design <− model.matrix(~0+tr+sex)
print(min(svd(design)$d))
# do Limma stuff
corfit <− duplicateCorrelation(quant_data[2:30],design, block=exp)
fit <− lmFit(quant_data[2:30], design, block=exp, correlation = corfit$consensus)
fit.eb <− eBayes(fit)





fit2 <− contrasts.fit(fit, contrastmatrix)
fit2.eb <− eBayes(fit2)
sig_changes <− decideTests(fit2.eb, p.value = 0.05, method="global", adjust.method="BH")
summary(sig_changes)
# Create Venn Diagram of the overlap between analysis groups
if(save_data){
png(filename = file.path(img_dir, "de_venn.png"), width=8, height=8, units="in", res=300)
vennDiagram(sig_changes, circle.col = c("red", "yellow"))




vennDiagram(sig_changes, circle.col = c("red", "yellow"))
title(main= "Number of differentially expressed proteins")
}
# get significantly differentially expressed proteins
sig_proteins <− data.frame(cbind(as.character(quant_data[,1]), sig_changes[,1:3]), stringsAsFactors = FALSE)
colnames(sig_proteins) <− c("protein", "Out_vs_Up","Down_vs_Up", "Out_vs_Down")
#### Get Protein IDs and symbols ####
# Grab all ID'd proteins from TPP dataset
prot_id_list <− prot_full_data[,c("protein","protein description")]
prot_id_list$protein <− lapply(prot_id_list$protein, trimws, which = "right")
# get list with description
sig_proteins <− merge(sig_proteins, prot_id_list, by=1, all.x=TRUE)
sig_proteins$ensembl_ID <− str_extract(sig_proteins$`protein description`,"ENSDAR[TP][0−9.]+")
sig_proteins$zfin_ID <− str_extract(sig_proteins$`protein description`, "ZDB−GENE−[0−9]+−[0−9]+")
sig_proteins$symbol <− lapply(sig_proteins$protein,
function(x) unlist(str_split(str_extract(x, "ENSDAR[TP][0−9.]+_+.*_"), "_+"))[2])
# separate out DE and background proteins
#sig_proteins <− sig_proteins[sig_proteins$Glen != 0 | sig_proteins$Downstream != 0,]
# get p−value and fold change for differentially expressed proteins
de_prots <− data.frame(cbind(fit2.eb$p.value, fit2.eb$coefficients, sig_changes))
#colnames(de_prots) <− c("p_value_out","p_value_down","logfc_out","logfc_down","out_sig","down_sig")
colnames(de_prots) <− c("p_value_out","p_value_down", "p_value_btwn","logfc_glen","logfc_down", "logfc_btwn",
"glen_sig","down_sig", "btwn_sig")
de_prots$protein <− quant_data$protein
de_prots <− merge(de_prots, sig_proteins[,c("protein","ensembl_ID","zfin_ID")], by.x = "protein", by.y = "protein",
all.x=TRUE)
de_prots <− data.table(de_prots)
#### Get consistent ensembl IDs for easier analysis and functional enrichment ####
de_prots[ensembl_ID %like% "ENSDAR", ensembl_ID := str_extract(ensembl_ID, "ENSDAR[PT][0−9]+")]














de_prots <− ensembl_data[de_prots, on=.(ensembl_ID), nomatch = NA]
de_prots[external_gene_name == "",]$external_gene_name <− NA













colnames(missing_transcripts)[colnames(missing_transcripts) %like% "zfin"] <− "zfin_id_id"













de_prots[missing_transcripts, on=.(ensembl_ID), (desired_attributes) := mget(paste0("i.", desired_attributes))]
de_prots[missing_proteins, on=.(ensembl_ID), (desired_attributes) := mget(paste0("i.", desired_attributes))]
de_prots[!is.na(zfin_ID), zfin_id_id := zfin_ID]
de_prots[, zfin_ID := NULL]
de_prots[, zfin_id_id := as.character(zfin_id_id)]
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de_prots[external_gene_name == "",]$external_gene_name <− NA
de_prots[zfin_id_id == "",]$zfin_id_id <− NA
# Do some cleanup for broken links
de_prots[external_gene_name == "cyp2k19",]$zfin_ID <− "ZDB−GENE−091211−1"
de_prots[external_gene_name == "cyp2k19",]$gene_id <− "ZDB−GENE−091211−1"
# This doesn't seem to get pulled, despite be linked in zfin
de_prots[ensembl_ID == "ENSDARP00000140915",]$external_gene_name <− "zgc:172341"
# This protein/transcript has been removed from current ensembl database
de_prots[ensembl_ID == "ENSDART00000158091",]$external_gene_name <− "zgc:101540"
# rename the 'ensembl_gene_id column so that if we have to update things it still makes sense
# colnames(de_prots)[colnames(de_prots) == "ensembl_gene_id"] <− "gene_id"
setnames(de_prots, c("ensembl_gene_id", "zfin_id_id"), c("gene_id", "zfin_ID"))
#### Save differentially expressed proteins ####
# Write out DE proteins
de_prots$name_1006 <− sapply(de_prots$name_1006, FUN=paste,collapse=";")















setnames(full_expression_data, c("gene_id", "protein"), c("NAME", "DESCRIPTION"))
if(save_data){
write.table(de_prots[glen_sig != 0 | down_sig != 0 | btwn_sig !=0,
],file=file.path(out_dir,"sig_de_proteins_with_descriptions.tsv"), sep="\t")
write.table(full_expression_data, file=file.path(out_dir, "expression_data_with_ens_gene_id.txt"), sep="\t",
row.names = FALSE, quote = FALSE)
}
# #### Write out file for DAVID and FGnet analysis ####
# # create an output directory for all the fgnet files
# fgnet_dir <− make_dir("fgnet_output", out_dir)
# print(paste("FGNet output will be stored in", fgnet_dir))
#
# # GLEN site
# fgnet_glen_aux <− fgnet_data_setup(de_prots[de_prots$glen_sig !=0,
# c("gene_id","external_gene_name", "glen_sig")], "glen_site", fgnet_dir)
#
# # FGNET doesn't understand how file paths work
# current_dir <− getwd()
# setwd(fgnet_dir)
# # format david results
# glen_david <− format_david(normalizePath("glen_site_david_clusters.txt"), geneLabels = fgnet_glen_aux$labels)
# # Generate FGNET stuff
# FGNet_report(glen_david, geneExpr = fgnet_glen_aux$expr, plotKeggPw=TRUE)
# setwd(current_dir)
#
# # Downstream site
# fgnet_downstream_aux <− fgnet_data_setup(de_prots[de_prots$down_sig !=0,
# c("gene_id","external_gene_name", "down_sig")], "downstream", fgnet_dir)
#
# # FGNET doesn't understand how file paths work
# current_dir <− getwd()
# setwd(fgnet_dir)
# # Upload david_expressed_proteins_down file to DAVID and save results of the analysis clustering
# # format david results
# down_david <− format_david(normalizePath("downstream_david_clusters.txt"), geneLabels = fgnet_downstream_aux$labels)
# # Generate FGNET stuff
# FGNet_report(down_david, geneExpr = fgnet_downstream_aux$expr, plotKeggPw=TRUE)
# setwd(current_dir)
Listing B.2: Python code for parsing high quality protein IDs from the full protein ID list in peptide
output data.
#! /usr/bin/env python3
import pandas as pd
import sys
from itertools import chain
import gffutils





# TransDecoder appends ".pX" to the end of each gene name, need to remove for the ID to match
feature = transcript_db[protein_id.rsplit(".",1)[0]]
return feature
def find_overlapping_genes(protein_list, predictions_db, transcript_db):
if len(protein_list) == 1:
return protein_list
if any([protein_id.startswith("DECOY") for protein_id in protein_list]):
return []
features_list = [get_gene_feature(protein, predictions_db, transcript_db) for protein in protein_list]
# if any of the gene features are on separate chromosomes assume they don't overlap
if len(set([feature.chrom for feature in features_list])) > 1:
return protein_list
feature_positions = [range(feature.start, feature.end) for feature in features_list]
feature_lengths = [len(coords) for coords in feature_positions]
largest_feature = feature_lengths.index(max(feature_lengths))
largest_coords = set(feature_positions[largest_feature])
if min([len(position)/len(largest_coords.intersection(position)) if len(largest_coords.intersection(position)) > 0
else 0 for position in feature_positions]) > 0.5:
protein_list = [protein_list[largest_feature]]
return(protein_list)
def clean_prot_list(prot_file, pep_file, augustus_db_location, zfin_db_location, contaminant_strings=None):
augustus_db = gffutils.FeatureDB(augustus_db_location)
zfin_db = gffutils.FeatureDB(zfin_db_location)
# Get the set of proteins passing the quality filter from the TPP output tsv
prot_dt = pd.read_csv(prot_file, sep="\t")
# split protein ids into a list by the delimiter and discard the last entry (empty string)
prot_dt["protein"] = prot_dt["protein"].str.split(" ").str[:−1]
prot_dt["protein"] = prot_dt["protein"].apply(find_overlapping_genes, args=[augustus_db, zfin_db])
proteins = set(chain(*prot_dt.protein))
# find all peptide that match to proteins from the filtered set
pep_dt = pd.read_csv(pep_file, sep="\t")
if contaminant_strings is not None:
for contaminant in contaminant_strings:
pep_dt = pep_dt[pep_dt["protein"].str.contains(contaminant)==False]
pep_dt['protein'] = pep_dt['protein'].apply(lambda protein:
list(set(protein.split(sep=",")).intersection(proteins)))
# Find all peptides that match to only one protein from the filtered set
uniq_prot_rows = pep_dt["protein"].str.len() == 1
uniq_pep_indx = pep_dt[uniq_prot_rows].index
uniq_pep_dt = pep_dt.loc[uniq_pep_indx, :]
uniq_pep_dt['protein'] = uniq_pep_dt['protein'].apply(lambda x: "".join(map(str,x)))
return [uniq_pep_dt, prot_dt]
if __name__ == '__main__':
if len(sys.argv) == 6:
out_dt = clean_prot_list(sys.argv[1], sys.argv[2], sys.argv[3], sys.argv[4])
out_dt.to_csv(path_or_buf=sys.argv[5], sep="\t")
else:
print("Usage: %s protein_id.tsv peptide_id.tsv, augustus_db, zf_db, output_file_name" % sys.argv[0])









make_dir <− function(dir_name, location="."){
full_path <− file.path(location, dir_name)
if(!file_test("−d", full_path)){
if(file_test("−f", full_path)){








quantify.proteins.vsn <− function(dat, cha, housekeeper_ids=NULL){
### Taken from http://www.biostat.jhsph.edu/~kkammers/software/CVproteomics/R_guide.html ###
e.function <− function(x, seq) tapply(x, seq, median)
output <− NULL






sdat <− subset(dat, Protein.Group.Accessions==id)[c("Sequence", cha)]
pdat <− sdat[, −1]
n.spectra <− ifelse(is.integer(dim(pdat)), nrow(pdat), 1)
temp <− apply(sdat[,−1], 2, e.function,seq=sdat[, 1])
n.peptides <− ifelse(is.integer(dim(temp)), nrow(temp), 1)
pdat <− apply(sdat[cha], 2, sum)
pdat <− c(pdat, n.peptides=n.peptides, n.spectra=n.spectra)
output <− rbind(output, pdat)
}
row.names(output) <− accessions
# test_dt <− data.table(output, keep.rownames = TRUE)
# setnames(test_dt, c("rn"), c("protein"))
# test_dt[,ionSum := rowSums(.SD), .SDcols = 2:11]
# unique_list <− lapply(colnames(test_dt)[2:11], function(sample_id){unique(test_dt[get(sample_id) == ionSum &
ionSum > 0,]$protein)})






plot_sum_intensity <− function(pep_dt, plot_title=NULL){




sum_intensity[, c("site", "run", "cage", "sex") := tstrsplit(reporter, "\\.")]
raw_intensity <− ggplot(sum_intensity, aes(x=reporter, y=value, fill=site)) +
geom_bar(stat="identity") +
theme_classic() +
ylab("Reporter Ion Intensity") +
xlab("Sample") +
ylim(c(0, 1.8e9)) +
labs(fill = "Caging Site") +
ggtitle(plot_title) +
scale_fill_brewer(type = "qual", palette = "Set1") +
theme(text = element_text(size=20), axis.text.x = element_text(angle = 90, hjust=0, vjust=0.5))
return(raw_intensity)
}






column_names <− as.character(colnames(intensity_dt[, ..column_list]))
setcolorder(intensity_dt, sort(column_names))
}
melt_data <− melt(intensity_dt[,..column_list], variable.name = "sample_id", value.name = "log_intensity")
melt_data[, c("site", "run", "cage", "sex") := tstrsplit(sample_id, "\\.")]
normalized_plot <− ggplot(melt_data, aes(x=sample_id, y=log_intensity, fill=site, linetype=sex)) +
geom_boxplot(notch = TRUE) +
theme_classic() +





labs(fill = "Caging Site", sex="Sex") +
theme(text = element_text(size=20), axis.text.x = element_text(angle = 90, vjust=0.5, hjust=0)) +
scale_fill_brewer(type = "qual", palette = "Set1")
return(normalized_plot)
}
plot_logfc_density <− function(normalized_matrix, column_list, plot_title=NULL){
melt_data <− melt(normalized_matrix[,column_list], variable.name = "Sample", value.name = "log2FC")
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p <− ggplot(data=melt_data, aes(x=log2FC, color=Sample, fill=Sample)) +
geom_density(alpha=0.01, size=1) +
scale_color_brewer(type="qual", palette = "Paired") +












image_path <− file.path(image_dir, image_name)





run.quant <− function(quant_dt_raw, design_table, minimum_reporters, drop_channels = NULL,
housekeeper_ids = NULL, img_dir = ".", save_plots = FALSE){





# rename TPP columns to something sensible − this need to be made flexible for tmt/itraq
quant_dt <− quant_dt_raw[,list(Protein.Group.Accessions = protein, Sequence = peptide,
tag126N = libra1, tag127N = libra2, tag127C = libra3,
tag128N = libra4, tag128C = libra5, tag129N = libra6,
tag129C = libra7, tag130N = libra8, tag130C = libra9,
tag131N = libra10)]
print(paste0("All: ", nrow(quant_dt)))
# for some reason data table breaks something below
quant_dt <− as.data.frame(quant_dt)
# get the last column so we can set the range for plotting/normalization
last_col <− ncol(quant_dt)
# convert columns from isobaric tag to sample name




quant_dt <− quant_dt[ , !(names(quant_dt) %in% drop_channels)]
sample_ids <− sample_ids[!(sample_ids %in% drop_channels)]
}
# get the total intensity for each sample/channel and plot it
img_1 <− paste(exp_label, "total_ion_inten.png", sep="_")
output_plot(plot_sum_intensity(quant_dt, NULL), img_dir, img_1)
# Remove peptides with zero intensity ions in more than x channels\
max_missing <− length(sample_ids) − minimum_reporters
quant_dt <− quant_dt[rowSums(quant_dt[,3:ncol(quant_dt)] == 0) <= max_missing,]
# Plot new intensity for each channel/sample
img_2 <− paste(exp_label, "filtered_ion_intensity.png", sep="_")
output_plot(plot_sum_intensity(quant_dt, NULL), img_dir, img_2)
cha <− sample_ids[order(sample_ids)]
number_channels <− length(cha)
print(paste0("Min Reporters: ", nrow(quant_dt)))
if ( !(is.null(housekeeper_ids)) ) {
peptide_correlation <− cor(quant_dt[quant_dt$Protein.Group.Accessions %in% housekeeper_ids,cha])
#peptide_correlation_title <− paste(exp_label, "Raw Peptide Level Correlation between Housekeeping Proteins")
peptide_correlation_title <− NULL
if (save_plots){
plot_file <− file.path(img_dir, paste(exp_label,"peptide_level_correlation.png", sep="_"))
png(filename = plot_file, width=8, height=8, units="in", res=300)
corrplot(peptide_correlation, type="upper", method = "number", title=peptide_correlation_title)
dev.off()
}else{
corrplot(peptide_correlation, type="upper", method = "number", title=peptide_correlation_title)
}
}
normalized_prot <− quantify.proteins.vsn(as.data.frame(quant_dt), cha, housekeeper_ids)
if ( !(is.null(housekeeper_ids)) ) {
protein_correlation <− cor(normalized_prot[rownames(normalized_prot) %in% housekeeper_ids, cha])




plot_file <− file.path(img_dir, paste(exp_label,"protein_level_correlation.png", sep="_"))
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png(filename = plot_file, width=8, height=8, units="in", res=300)








normalized_prot[,1:number_channels] <− normalized_prot[,1:number_channels] −
apply(normalized_prot[,1:number_channels], 1, median)
quantified_prot <− as.data.frame(normalized_prot)
quantified_prot <− subset(quantified_prot, quantified_prot$n.peptides > 1)
#quantified_prot[quantified_prot == 0] <− NA
quantified_prot <− na.omit(quantified_prot)
img_6 <− paste(exp_label, "normalized_logFC_density.png", sep="_")
output_plot(plot_logfc_density(quantified_prot, column_list = cha), img_dir, img_6)
quantified_prot <− data.frame(protein = row.names(quantified_prot), quantified_prot)
return(quantified_prot)
}










get_biomart_attributes <− function(ensembl_transcript_id_list, attribute_list, filter, host =
"Dec2017.archive.ensembl.org"){
ensembl = useMart('ENSEMBL_MART_ENSEMBL', dataset="drerio_gene_ensembl", host)
prot_go_mapping <− getBM(mart=ensembl,attributes = c(filter, attribute_list),
filters=filter, values=ensembl_transcript_id_list)
colnames(prot_go_mapping) <− c("ensembl_ID", attribute_list)
out_dt <− data.frame()
if(length(unique(prot_go_mapping[,1])) < dim(prot_go_mapping)[1]){






out_dt$description <− sapply(out_dt$description, unlist_ensembl_attributes)
}
if("external_gene_name" %in% colnames(out_dt)){
out_dt$external_gene_name <− sapply(out_dt$external_gene_name, unlist_ensembl_attributes)
}
if("ensembl_transcript_id" %in% colnames(out_dt)){
out_dt$ensembl_transcript_id <− sapply(out_dt$ensembl_transcript_id, unlist_ensembl_attributes)
}
if("ensembl_peptide_id" %in% colnames(out_dt)){
out_dt$ensembl_peptide_id <− sapply(out_dt$ensembl_peptide_id, unlist_ensembl_attributes)
}
if("ensembl_gene_id" %in% colnames(out_dt)){
out_dt$ensembl_gene_id <− sapply(out_dt$ensembl_gene_id, unlist_ensembl_attributes)
}
if("zfin_id_id" %in% colnames(out_dt)){
out_dt$zfin_id_id <− sapply(out_dt$zfin_id_id, unlist_ensembl_attributes)
}
if("zfin_id" %in% colnames(out_dt)){








file_prefix <− file.path(out_dir, file_label)
de_gene_id_file <− paste(file_prefix, "de_protein_list.csv", sep="_")
write.table(na.omit(gene_ids), file = de_gene_id_file, row.names = FALSE,
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col.names = FALSE, quote = FALSE)
print(paste("Upload", de_gene_id_file, "to DAVID for functional analysis"))
expression_pattern <− setNames(significance, gene_labels)
write.table(expression_pattern, file = paste(file_prefix, "expr_pattern.csv", sep="_"))
label_to_id_map <− setNames(gene_labels, gene_ids)
write.table(label_to_id_map, file=paste(file_prefix, "label_id_map.csv", sep="_"))





(a) a) (b) b) (c) c)
Figure B.1: Sum of reporter ion intensity for the 10 reporter tags in each of the 3 mass spectrometry runs.
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Figure B.2: Pearson correlation of PSM intensities between samples in mass spectrometry run B.
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Figure B.3: Pearson correlation of PSM intensities between samples in mass spectrometry run C.
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Figure B.4: Pearson correlation of housekeeping-protein expression between samples in mass spectrometry
run A.
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Figure B.5: Pearson correlation of housekeeping-protein expression between samples in mass spectrometry
run B.
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Figure B.6: Box plot of the Log2 fold-change for each sample in the three mass spectrometry runs.
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Figure B.7: Overlap between differentially expressed proteins in the different contrasts.
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B.4 Outlier Removal
Figure B.8: Intra-run correlation of housekeeping-protein intensities aftervariance stabilized normalization
(VSN) for mass spectrometry run C, including sample H22X.C.2.M. The correlation between sample
H22X.C.2.M and all other samples is noticeably lower, with a maximum correlation score, 0.94, comparable
to the lowest of all other sample correlations, 0.93.
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Figure B.9: Normalized Log2 fold-change (Log2 fold-change) of samples in run C, including the outlier
sample H22X.C.2.M. The interquartile range is larger than for other samples in the same sample.
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Figure B.10: Density plot of normalized Log2 fold-change of samples in run C, including the outlier
sample H22X.C.2.M. Distributions of different samples are coloured separately, with the outlying sample
(H22X.C.2.M) in dark orange. The greater variance is visible at the base of the distribution, particularly
for proteins with negative log-fold changes.
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Figure B.11: multidimensional scaling (MDS) plot of normalized protein Log2 fold-change. The label next
to each point indicates which of the three mass spectrometry runs (A-C), sample cage (1 or 2), and the sex
(M or F) of the sample. The outlying sample, H22X.C.2.M can be found in the lower right of the figure.
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Figure B.12: Heatmap of samples. Samples with similar expression patterns are grouped together.
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B.5 KEGG Diagrams
Figure B.13: Differential expression of proteins involved in the Glutathione Metabolism pathway. PGD
(EC 1.1.1.44), GPX4a (EC 1.11.1.12) and multiple GST proteins (EC 2.5.1.18) were significantly increased,
G6PD (EC 1.1.1.49), GSR (EC 1.8.1.7) and zgc:152830 (PepA) were increased, but not significant. IDH1
(EC1.1.1.42) was downregulated, but not significantly.
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